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 Diabetes mellitus affects 25.8 million Americans (8.3%) and over 300 million people 
worldwide. Clinical trials indicate that proper management of blood glucose levels is critical in 
preventing or delaying complications associated with diabetes. Thus, there is a common need to 
monitor and manage blood glucose properly for people with diabetes. However, the patients’ 
compliance for recommended monitoring frequency is low due to the pain and inconvenience of 
current standard finger-pricking tests. To promote patient adherence to the recommended self-
monitoring frequency, non-invasive/ minimally invasive glucose testing approaches are needed. 
Luminescent microparticle sensor is an attractive solution. For these sensors to be deployed in 
vivo, a matched optical system is needed to interrogate dermally-implanted sensors. This 
research project investigated the light propagation in skin and the interaction with implants using 
Monte Carlo modeling. The results of the modeling were used to design an optical system with 
high interrogation and collection efficiency (40~300 times improvement). The optical system 
was then constructed and evaluated experimentally. A stable skin phantom mimicking the optical 
properties of human skin was developed as a permanent evaluation medium to minimize the use 
of animals. The optical properties of the skin phantom matched the maximum published values 
of human skin in scattering and absorption over the spectral range of 540~700nm in order to 
avoid overestimation of the capability of the system. The significant photon loss observed at the 
 iv 
connection between the designed system and a commercial spectrometer was overcome using 
two optimized designs: a two-detector system and a customized low-resolution spectrometer 
system. Both optimization approaches effectively address the photon loss problem and each 
showed good SNR (>100) while maintaining a sufficient system resolution for use with 
fluorescent materials. Both systems are suitable for luminescence measurement, because broad 
bands of the luminescent spectrum are of interest. In the future, either system can be easily 
modified into a more compact system (e.g. handheld), and it can be directly coupled to an 
analog-to-digital converter and integrated circuits offering potential for a single compact and 
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I intensity of transmitted light 
I0 intensity of incident light 
T transmission of light 
µa absorption coefficient 
µs scattering coefficient 
µs’ reduced scattering coefficient 
σ absorption cross section 
P density of absorbers 
l path length of light 
g anisotropy factor 
χ a random variable 
ξ a computer generated random number 
s photon’s free path length 
µt interaction coefficient 
MT diffuse transmittance 
MR diffuse reflectance 
MC collimated transmittance 
w weight of a photon in Monte Carlo modeling 
n refractive index 
λ wavelength 
D diameter of the spheres of sensor model (μm) 
S center-to-center spacing of the spheres of sensor model (μm) 
 viii 
C concentrations of glucose (mg/dL) 
t time 
T diffuse transmission measured with an integrating sphere 
T0 diffuse transmission without a sample 
R diffuse reflection measured with an integrating sphere 
R0 diffuse reflection without a sample 
U collimated transmission 
U0 collimated transmission without a sample 
N groove density of a grating (1/mm) 
N’ total number of grooved illuminated 
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Disturbance of biochemical substances in the body may indicate or cause medical or 
pathological conditions. For example, hypoxia (low oxygen) has been implicated in central 
nervous system pathology in a number of disorders including stroke, head trauma, neoplasia and 
neurodegenerative disease [1]. Elevated levels of uric acid accumulation can lead to gout, a 
painful arthritis; iron deficiency increases perinatal risks for mothers and overall infant mortality. 
Deficiency of iodine can cause mental retardation and brain damage [2]. Elevated lactate levels 
(>4mM) have been shown to be associated with circulatory failure and cardiac arrest [3]. 
Hypercholesterolemia is strongly associated with cardiovascular disease [4]. High levels of 
blood glucose may mark diabetes. To facilitate diagnosis or management of these medical 
conditions, it is important to develop technologies for sensing these biochemicals.  
 Among these available biochemical sensing technologies, glucose sensing is of special 
significance, because of the epidemic of diabetes. Diabetes mellitus affects 23.6 million 
Americans (7.8%) and over 300 million people worldwide; moreover, this total is expected to 
reach close to 500 million within 20 years [5, 6]. There are three main types of diabetes. Type 1 
diabetes is called insulin-dependent diabetes and it results from the body’s failure to produce 
insulin. Type 1 diabetes accounts for 5-10% of all diagnosed diabetes. Type 2 diabetes is called 
non-insulin-dependent diabetes. It usually results from insulin resistance, a condition in which 
cells fail to use insulin properly. This type of diabetes accounts for 90-95% of all diagnosed 
diabetes. Gestational diabetes is temporary and occurs during pregnancy. However, women who  
____________ 
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have had gestational diabetes have a 40-60% chance of developing diabetes in the next 5-10 
years. There are many serious complications associated with hyperglycemia that results from  
lack of glucose control due to diabetes, and the complications include cardiovascular disease, 
blindness, kidney damage, stroke, hypertension, lower-limb amputations, nephropathy, 
neuropathy, periodontal, gingivitis, cataract formation, and pregnancy difficulties [6, 7].  
 People with diabetes can still lower the occurrence or delay the progression of these 
complications by controlling blood glucose properly. People can use the results of glucose 
monitoring to make decisions about physical activity, food, and medications in order to control 
their glucose levels [8]. Clinical trials prove that proper management of blood glucose levels is 
critical in preventing or delaying the complications [9-11]. Therefore, all persons with diabetes 
share a common need to monitor and manage their blood glucose state properly. 
 The current gold-standard methods for patients to monitor blood glucose levels by 
themselves is the “finger-pricking” test, which requires lancing the skin to extract a blood 
sample that is then examined by a device using disposable test strips. This method is 
inconvenient, painful and introduces potential infections. Therefore, compliance to the 
recommended blood testing frequency (at least 3 times/day) is typically poor due to 
inconvenience and pain [12-14]. To enable better glucose control, the continuous glucose 
monitoring system (CGMS) has been recently developed to be commercially available. The 
purpose of CGMS is to provide continuous information of trends, magnitude and fluctuations of 
glucose instead of 3-4 blood measurements per day. These systems use a tiny sensor inserted into 
the skin to check glucose concentrations in tissue fluid. The sensor stays in place for several days 
to a week and then must be replaced. CGMS devices produced by DexCom (STS® Seven 
system), and Medtronic (Guardian® RT) have been approved by the U.S. Food and Drug 
Administration and are available for prescription. However, these devices still require 
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percutaneous insertion, which introduces potential infection pathway, and they have accuracy 
issues. Moreover, CGMS is not intended to replace day-to-day long-term glucose monitoring by 
patients themselves. Therefore, a less painful and more convenient way to facilitate self-
monitoring of blood glucose is needed to promote patient adherence to recommended self-
monitoring glucose testing. A number of studies about noninvasive/minimally-invasive glucose 
sensors are being pursued worldwide. Noninvasive/minimally-invasive sensing technologies are 
not only important to people with diabetes, but also are effective platform technologies that are 
critical for monitoring of other biochemical substances or nutrients to assess overall health [2].  
 
1.2 Background 
Currently, many potentially less invasive optical sensing technologies are under investigation 
including absorption spectroscopy, polarimetry, Raman spectroscopy, and 
fluorescence/phosphorescence [2]. Among these sensing technologies, fluorescence-based 
glucose sensing has the advantage of being highly sensitive and highly specific to the target 
analyte. Combinations of highly sensitive luminescence transduction methods with fiber-optic 
technology have shown particular promise [15-19]. These devices generally employ a probe 
consisting of a luminescence chemical assay immobilized within a selectively permeable 
membrane at the tip of an optical fiber. However, these fiber-optic transducers are still invasive 
during each measurement and have not been proven to meet the stability or reliability 
requirements for long-term in vivo functionality [20]. Dermally implanted luminescence-based 
microparticle biosensors are attractive alternatives, because the sensing chemistry is detached 
from the fiber tip, which enables completely noninvasive monitoring in vivo [2, 21-24]. 
 The McShane group has previously reported several different luminescent chemo-optical 
transducer platforms that may meet the needs of such implantable biosensors; these include 
 4 
examples of glucose sensors based on self-assembled hybrid microparticles and microcapsules 
[25-29]. One of these systems is based on the enzymatic oxidation of glucose catalyzed by the 
glucose oxidase (GOX) enzyme (Glucose+O2+H2O →Gluconic Acid+H2O2), which consumes 
oxygen as a co-substrate [29, 30]. Microparticle sensors are fabricated by loading glucose 
oxidase and immobilizing Pt(II) octaethylporphine (PtOEP) (a phosphorescent dye readily 
quenched by oxygen) inside the particles, and Rhodamine B-doped multilayer nano-film coating 
on the surfaces of microparticles provides reference emission, as well as transport control. 
Because oxygen inside each microparticle is depleted in proportion to glucose concentration, 
glucose can be indirectly monitored by measurement of PtOEP emission, which senses oxygen 
levels. Thus far, reaction-diffusion modeling and in vitro results suggest that these sensor 
systems can achieve adequate sensitivity, reliability, and longevity for long-term monitoring in 
vivo [29-32]. 
 However, to deploy and interrogate luminescence-based dermally implanted sensors in 
vivo for on-demand monitoring, a number of key technical hurdles must be overcome. The 
microparticles must be engineered to be biocompatible, stable and produce signals strong enough 
for trans-dermal measurements. Assuming that this can be accomplished, it is also necessary to 
design a matched optoelectronic system to interrogate our dermally-implanted microparticle 
sensors. This system needs to be compact, portable, and of high efficiency to deliver excitation 
light, collect luminescence, and measure luminescence. A bifurcated optical fiber bundle is 
commonly used to deliver excitation light and to collect luminescence from a scattering medium, 
but the collection efficiency is limited because locations for the delivery of excitation light and 
those for collection of the luminescence are separate, thus the loss of luminescence, where the 
excitation light goes in is inevitable. To our knowledge, there is no commercial product or 
research report of a hardware design with high efficiency that is suitable for interrogation of 
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dermally-implanted sensors. The aim of this research was to develop a hardware system that will 
overcome the shortcomings of current bifurcated optical fiber.  
 
1.3 Organization of sections 
The sections of this dissertation have been organized so that the disseminated material is 
presented in a clear and logical sequence. Section 2 provides the theory of optical properties and 
Monte Carlo modeling for luminescence photon transportation in tissue. Section 3 is dedicated to 
modeling photon transportation in skin and the interaction with implants. Section 4 describes the 
optical design of the hardware system for sensor interrogation based on the modeling results 
obtained from the study in Section 3, and the corresponding experimental evaluation that was 
performed. This section also describes a skin phantom mimicking the optical properties of skin, 
which was developed as an evaluation medium for hardware testing. Section 5 focuses on the 
optimization work of the hardware system designed in Section 4 due to the inevitable photon 
loss observed during system evaluation performed in the last section. Section 6 concludes the 
work presented in this dissertation and discusses the implications of the research, and proposes 







2. THEORY OF TISSUE OPTICS AND MONTE CARLO MODELING 
 
2.1 Optical properties 
Optical properties of tissues are expressed in optical parameters such as absorption coefficient 
(μa), scattering coefficient (μs), anisotropy factor (g), refractive index (n), effective attenuation 
coefficient (μeff) and so on. The primary optical parameters used in all types of modeling for 
photon propagation in tissue are μa, μs, g, and n. To simulate luminescence, the quantum yield 
(Ф) will be used. These parameters characterize photon propagation in tissue, and they are 
obtained by calculating the measurement of observable quantities such as reflection, and 
transmission, etc. [33] 
 
2.1.1 Absorption 
The absorption process involves the interaction of the molecule in the ground state with a photon 
to promote an electron from a lower energy to a higher energy molecular orbital [34]. In 
biological tissues, there are several major absorbers. Protein and DNA are the main ultraviolet-
absorbers, and the absorption increases as the wavelength gets shorter. Water is strong infrared 
absorbers and the absorption increases with longer wavelength. Whole blood is a strong absorber 
in the red-NIR regime, but the volume fraction is a few percent in tissue, thus the average 
absorption affecting light propagation in tissue is moderate except in blood vessels. 
Melanosomes are strong absorbers, as well, and most melanosomes are in epidermis and it varied 
a lot among different types of skin. Compared with other wavelength band, the absorption at red-
NIR is relatively low, therefore, this region is called the diagnostic and therapeutic window [35, 
36]. 
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 The absorbance of a substance is proportional to the concentration of absorbing species 
(Beer’s law) in a substance of path-length (l) traversed by incident light (Lambert’s law) [34]. 
The Beer-Lambert law states that there is a logarithmic dependence between the transmission (T) 
of light through a substance and the product of the absorption coefficient (µa) [length-1] of the 
substance and the distance the light travels through the substance (l) [37], which is shown as in 
Equation (1). The absorption coefficient can be written as a product of a molar absorptivity (ε) of 
the absorber and the concentration of absorbers in the material, or it can be written as the product 
of absorption cross section (σ) and the (number) density (P) of absorbers. The absorption 
coefficient (µa) is defined as the probability of photon absorption per unit infinitesimal path-
length [38]. Experimentally, the units for absorption coefficient (mm-1 or cm-1) are inverse 
length. According to Beer-lambert law, the relationship between the intensity of incident light 


















Photo-luminescence is a radiative transition resulting from absorption of photons. There are two 
types of photo-luminescence: fluorescence and phosphorescence [39]. The Jablonski diagram 
(Figure 1) shows that there are various transitions open to the excited state after population to the 
ground state. In Figure 1, the solid arrows are radiative transitions as occurring by absorption or 
emission of a photon and dashed arrows represent non-radiative transitions. Internal conversion 
and intersystem crossing are two types of non-radiative transitions. Internal conversion occurs 
between states of the same spin multiplicity. A molecule that is directly excited into a state 
which is higher than S1 will relax by internal conversion to S1 state before emission can occur. 
Intersystem crossing (S1 to T1) is a non-radiative transition between states of different spin 
multiplicity and occurs via inversion of the spin of the excited electron [34]. Fluorescence takes 
place on the nanosecond scale and always emitted from the states of zeroth vibrational level of 
the first excited singlet state (S1). Phosphorescence is originated from the triplet state (T1). Once 
the molecule has reached triplet state, it will reside for a certain time (more than microseconds) 
before it decays to the ground state. This is because of the spin-forbidden transitions involved in 
the excited singlet-triplet and triplet-singlet (ground state) transitions. Therefore, the 
phosphorescence has longer lifetime [40].  
 Quantum yield (Φ) of luminescence is defined as the ratio of number of luminescence 
photon emitted to the number of photons that absorbed. The maximum luminescence quantum 
yield is 1, which means every photon absorbed results in a photon emitted. Compounds with 






Figure 1. Jablonski diagram [40] 
 
 
2.1.3 Scattering   
Scattering of light is a general physical phenomenon where photons are forced to deviate from a 
straight trajectory by one or more localized non-uniformities in the medium through which they 
pass [42]. Light scattering occurs in media that contains variations in the refractive index (n), 
and such fluctuations can be discrete particles (scatterers) or more continuous variations in 
refractive index [43]. In biological tissues, there are many ultrastructures which can be scatterers. 
Membranes, collagen fibers, mitochondria nuclei, etc. are all biological scatterers. Scattering of 
light by the ultrastructres on the same size scale as wavelength can be described by Mie Theory, 
and structures which are much smaller than the wavelength can be described by Rayleigh 
scattering [44]. 
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  The scattering coefficient (μs) is defined as the probability of photon scattering per unit 
infinitesimal path-length [38]. Experimentally, the units for scattering coefficient (mm-1 or cm-1) 
are inverse length. The angular dependence of scattering is called the scattering function, p(θ), 
which describes the probability of a photon scattering into a solid angle oriented at an angle (θ) 
relative to the photon’s original trajectory. The Henyey-Greenstein scattering function is an 
expression which mimics the angular dependence of light scattering by small particles, which 
was initially used to describe scattering of light by interstellar dust clouds. This scattering 
function has proven to be useful in approximating the angular scattering dependence of single 
scattering events in biological tissues [45]. The Henyey-Greenstein function is as below in 
Equation (2): 
 
 (    )  
    
 (           )   
 (2)  
 
g is the anisotropy factor and it is dimensionless. It is a measure of the amount of forward 
direction retained after a single scattering event. It is defined as the expectation value for cos(θ) 
as demonstrated in Equation (3), θ is the deflection angle from the original trajectory.  
 
  ∫    ( )                  
 
 
 (3)  
 
 
2.1.4 Mean free path 
In optics, the mean free path is the average distance covered by a moving photon between 
successive impacts [46] which modify its direction or energy or other properties [47]. When 
photons travel in biological tissues, the mean free path between photon-tissue interaction sties is 
 11 
10-1000µm, and 100 µm is a typical value in the visible spectrum [33, 38]. The interaction 
coefficient μt is the probability of photon interaction per unit infinitesimal [38]. The interaction 
coefficient μt  is equal to μa+μs, thus a mean free path between photon-tissue interaction sites is 
1/ μt, since μa and μs describe the average number of absorption and scattering events happening 
within a unit length. 
 
2.2 Theory of Monte Carlo modeling 
2.2.1 Sampling random variables 
Monte Carlo modeling relies on the random sampling of variables from pre-defined probability 
distributions. A random variable χ is needed by modeling of photon propagation in medium. This 
variable can be the variable step size of a photon or the angle of deflection due to scattering [38]. 
The probability density function defines the distribution of χ over the interval (a,b) is as below in 
Euqation (4): 
∫  ( )     
 
 
 (4)  
 
 To simulate photon propagation, a value for χ will be chosen repeatedly and randomly 
based on a pseudo-random number generator. A computer can provide a random variable (ξ) that 
is uniformly distributed over the interval (0,1). The cumulative distribution function of this 
uniformly distributed random variable is as below in Equation (5): 
 ( )  {
                 
             
                 
 (5)  
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 To sample a non-uniformly distributed function p(χ), χ=f(ξ) is assumed to be a non-
decreasing function that maps   (   ) to   (   ). The variables ξ and χ have a one-to-one 
mapping. This mapping approach leads to the equality of probabilities as below. 
   ( )     (  )              
(6)  
 
If f(0)=a and f(ξ)= χ1,  thus Fχ(χ1)=Fξ(ξ1) 
Thus , Equation (7) can be converted into: 
∫  ( )   
  
 
  (  )    (  )     (7)  
 
 
2.2.2 Moving photons 
When the photon is launched or leaving the boundary, if the refractive index mismatch at the 
interface, specular reflection occurs. Specular reflectance (Rspe) can be calculated by Fresnel 
equation. 
∫  ( )   
  
 
  (  )    (  )     (8)  
 
 
     (
               
               
)  (9)  
 
 
Similarly, transmittance (Tspe) is: 
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          (10)  
 
In equation (9), n1 and n2 are the refractive index of medium where incident light and transmitted 
light travels. θi and θt are the angles of incident light and refracted light.  
 The step size of photons is sampled based on the probability distribution of photon’s free 
path s (s>0). According to the definition of interaction coefficient μt, which is the probability of 
interaction per unit path-length in the interval (s’,s’+ds’), thus the equation describes μt  is as 
below [38]: 
   
         
          
 (11)  
 
This cumulative distribution function can be assigned to the uniformly distributed random 
number ξ. Therefore Equation (11) can be converted to:  
 
    
  (   )
  
 (12)  
 
And after substituting ξ for 1- ξ, the photon step size is as below. Therefore, the photon step size 
(s) can be sampled by a random value (ξ) generated by computer. 
   
  ( )
  
 (13)  
 
Because the statistical average of –ln(ξ) : <-ln(ξ)>=1, the mean free path between photon-tissue 
interaction is 1/μt.. Once the photon step size is sampled, the photon is ready to be moved in a 3-
D way. 
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2.2.3 Photon absorption  
After the photon takes a step, the attenuation of the photon weight due to absorption will be 
calculated. The fraction of the attenuated photon’s weight (Δw) is the ratio of µa to µt. Thus the 
updated photon’s weight is [38] : 






2.2.4 Photon scattering 
After the photon has been moved and the photon’s weight has been updated, the photon is ready 
to be scattered. The deflection angle,       )  and azimuthal angle        )  will be 
sampled. The probability distribution p(cosθ) for the cosine of deflection angle (θ) is described 
by Henyey-Greenstein function. Anisotropy factor (g) equals <cosθ>, thus g=0 indicates 
isotropic scattering and g=1 indicates very forward scattering. The choice for cosθ can be 
expressed as a function of random number ξ [38]. 
     {
 
  
[     (
    
       
)
 
]            
                                                                
 (15)  
 
Because the azimuthal angle (ψ) is uniformly distributed , thus it is sampled by 
 
      
(16)  
2.2.5 Luminescence propagation 
 The luminescence illumination at each step for each excitation and each emission 
wavelength is calculated [48] using the equation below: 
 (17)  
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      (   
      ) 
 
E is the excitation energy at the previous step, Φ is the quantum yield at excitation wavelength ; 
m is the emission factor for emission wavelength that is normalized from emission spectrum; μax 
is the absorption coefficient of excitation wavelength, and l is the previous step size before 
luminescence takes place. After emission, the luminescence photon goes through the absorption 









2.2.6 Photon termination [38] 
A photon can be terminated naturally by escaping from the medium. For a photon still 
propagating which has such little weight can occupy a lot computation resource. Therefore, 
proper photon termination must be executed to conserve energy without compromising the 
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distribution of photon energy deposition. The roulette technique is used to terminate photon. The 
roulette give the photon one chance in m of surviving with a weight of mw. If the photon does 
not survive, its weight is reduced to zero and it is terminated. 
 
  {
              








3. INVESTIGATION OF PHOTON TRANSPORTATION AND INTERACTION WITH 
IMPLANTS IN SKIN* 
 
3.1 Significance and background 
To assess the sensor performance in an implantation environment and to optimize the sensor 
configurations, it is necessary to evaluate how various tissue, particle, and particle distribution 
characteristics affect the measurement performance. These aspects include the size and tissue 
concentration of microparticle sensors, particle implantation depth, and scattering and absorption 
of light by tissue. Intuitively, one would expect implantation depth to influence the measurability 
of luminescence, because the attenuation of optical signal is proportional to the path-length of 
photon propagation. One might also anticipate that tissue scattering and absorption will result in 
distortion of spectral information from implants, due to the wavelength-dependent nature of 
tissue optical properties. The size of implants will affect the luminescent intensity, due to 
changing probability of excitation, whereas the particle concentration may result in different 
spectral distortions from tissue due to different spacing between particles. Finally, for the design 
of an efficient system for collection of escaping luminescence, it is also critical to determine the 
spatial distribution of escaping fluorescence. 
 Simulations can be of immense value in modeling this situation, allowing insight into the 
key parameters affecting escaping luminescence and guiding the design process.  Monte Carlo 
modeling has been applied to simulate light propagation in tissues for nearly two decades [49].  
The Monte Carlo method was coined by John von Neumann, Stanislaw Ulam and Nicholas 
Metropolis in 1940s, while they were working on Manhattan project in the Los Alamos National 
Laboratory [50]. Monte Carlo method uses random sampling to compute the results and it has 
been used to solve a variety of physical problems. In the application of Monte Carlo method, the 
*Part of this section is reprinted with permission by R. Long and M. J. McShane, 2010,  
Journal of Biomedical Optics, 15, 027011, Copyright 2010 SPIE;  R. Long, S. Singh, and M. 
J. McShane, 2008,  Proc. SPIE, 686307, Copyright 2008 SPIE (2008). 
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expected value of a certain random variable in a stochastic model is equivalent to the value of a 
physical quantity to be determined. This method is most suited to calculation by a computer and 
tends to be used when it is infeasible to compute an accurate result with a deterministic 
algorithm [50]. Monte Carlo modeling offers a flexible yet rigorous approach toward photon 
propagation in turbid tissues. The modeling describes the photon transportation as the probability 
distributions of step size of photon movement and the angles of deflection [38].  
 As a computational modeling tool, Monte Carlo modeling can facilitate understanding of 
light distribution in tissues, as well as validation of analytical models of light transport [51]. A 
large number of studies have employed Monte Carlo simulations to assess the effect of excitation 
and emission geometries, sample dimensions, and absorption and scattering coefficients of 
sample fluorescence [52-60]. Monte Carlo has also been employed to investigate the relationship 
between the fluorescence originating from different layers within the tissue and the observed 
bulk tissue fluorescence spectrum [61-64]. A number of groups have employed Monte Carlo 
code in design of optical diagnostic instrument design. The optical diagnostic methods include 
laser Doppler flow-metry [65-79], fluorescence spectroscopy [80-86], reflectance spectroscopy 
[59, 87-90], and so on. For many optical diagnostic instrument designs, the design of fiber-optic 
probe is of great significance, because it is associated with signal intensity, sensitivity, resolution 
or signal-to-noise ratio. To design a fiber-optic probe, a lot of Monte Carlo modelings have been 
carried out to evaluate the effect of parameters of fiber-optic probe and the optical properties of 
tissue models. The parameters of fiber-optic probe include numerical aperture, diameter, source-
detector distance, fiber orientation, shape of the fiber tip, and so on. Keijzer et al’s paper [53] 
might be the first work of using Monte Carlo modeling to simulate fluorescent light propagation 
in turbid media. Pfefer et al [55, 85, 91] extensively studied the effects of numerical aperture, 
fiber diameter, source-detector separation, and probe-to-tissue distances on the fluorescence 
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detection. Qu et al [58, 59] used Monte carlo modelings to determine appropriate excitation-and-
collection geometries with which the distortion of fluorescence spetra due to optical properties of 
tissues could be minimized. Jaillon et al[81] used the Monte Carlo simulation to design a beveled 
fiber-optic probe for improving the depth-resolved fluorescence measurement. Pogue et al’s 
paper [56] is a typical example of using Monte Carlo code to design a fiber probe for 
quantitative fluorescence detection that could reduce the effect of intrinsic absorption and 
scattering in local background. For depth-resolved reflectance spectroscopy, Arifler et al’s work 
[80] demonstrated the use of Monte Carlo code to design a compact fiber-optic probe capable of 
resolve reflectance spectra from two successive layers of biological tissue. Zhu et al’s paper [92] 
demonstrated the use of Monte Carlo code to design a fiber-optic probe for depth-resolved 
fluorescence measurement. The time-resolved Monte Carlo code is also a powerful 
computational tool for studies of time-resolved spectroscopy [93-96]. 
 In previous study, McShane el at introduced the use of Monte Carlo to model the transport 
of light through human skin and interaction with a subcutaneous (e.g. implanted) fluorescent 
sensing layer; in this work, a sensitivity study was performed to elucidate the effects of changing 
of optical properties and tissue and sensing layer characteristics on the escaping fluorescence 
[20]. While these previous studies have given insight into the key parameters affecting the 
observation of light produced by luminescent implants, two issues with these previous studies 
limit their broad applicability: (1) the restriction to flat (slab), uniform (homogeneous in x-y 
plane) geometries and (2) a single pair of excitation and emission wavelengths. These studies fall 
short of describing real microparticle-based systems with broadband emission relevant for 
sensing, and the information obtained is therefore insufficient for the design for an optical 
system to be employed for in vivo measurement. Instead, the interaction between light and skin 
as well as implanted microparticle sensors should be more accurately modeled with 3D, multi-
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wavelength Monte Carlo simulations. Verkruysse et al’s paper [97] analyzed the consequences 
of assumption of homogeneous model. The authors concluded that homogeneous model tended 
to attenuated more than the discrete absorber models, which intensified the necessity of using 3D 
modeling. OptiCAD, a recently-released commercial package allowing Monte Carlo ray tracing, 
has enabled this 3D modeling work. 
 In this Chapter, Monte Carlo modeling was applied to predict the characteristics of 
fluorescence escaping from tissue containing implanted microparticle sensors.  The properties of 
the implanted particles (depth, size, spacing, spectral features) and the light source diameter were 
varied to determine the effects of these parameters on emitted light.  The relative output power, 
spectral information, and the spatial distribution of escaping fluorescent emission were estimated 
and compared. The findings from these modeling studies supported the potential of in vivo 
measurement used implanted microspheres, and facilitated the design of hardware. 
 
3.2 Methods 
3.2.1 Software verification 
Before using OptiCAD (V10.033) as modeling software, it was verified by analytical modeling 
method and MCML [98](Mote Carlo Modeling of light transport in multi-layered tissues in 
standard C). One-dimensional diffusion calculation for fluorescence [99] was carried out with 
MATLAB as the analytical modeling. A multi-layered tissue model and a fluorescent slab were 
used in the modeling. In analytical modeling, every model was 1-D, while in OptiCAD all the 
models were 3-D. The fluorescence escaping from the surface of the tissue model was collected 
by a photon capture film (Figure 3) in OptiCAD. In Figure 4, the discrete data points were 
obtained from OptiCAD, and the solid line was obtained from analytical modeling. A 3-D 
fluorescent slab were Thus, Figure 4 shows that the modeling results obtained from these two 
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approaches agreed well. Figure 5 shows the modeling results of transmittance after a slab with 
scatters and absorbers, and the results obtained from OptiCAD and MCML agreed well. 
According to the verifications with two types of approaches, it was concluded that it is reliable to 









Figure 4. Compare analytical modeling and OptiCAD. Discrete data points were obtained from OptiCAD, 






































3.2.2 Configuration of modeling system and optical properties 
The modeling system was mainly consisted of a four-layered skin model and microsphere model. 
The four-layered skin model used in simulations was generated from an eight-layered model 
used by Zeng et al [62] to mimic the anatomical structure and optical properties of skins. The 
scheme of skin model is shown in Figure 6. The eight-layered model is simplified into a four-
layered model comprising one layer above the reticular dermis, a reticular dermis layer, a layer 
below the reticular dermis, and a subcutaneous fat layer. Stratum corneum (SC) is 10μm, 
epidermis (ED) is 80μm, papillary dermis (PD) is 100μm, reticular dermis (RD) is 1500μm, 
dermis is 160μm, upper blood plexus (UBP) is 80μm; lower blood plexus (LBP) is 70μm, and 
subcutaneous fat is 2mm. In Figure 6, SC+EP+PD+UBP=Upper dermis (270μm), RD = Dermis 






















5mm (MCML) 10mm (MCML)
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(270 μm to 1770 μm), where the microparticle sensors are intended to be introduced and retained 
in the tissue much like cosmetic dermal-filling agents or tattoos [100], therefore all of the skin 
layers above or below the reticular dermis were assumed to be homogeneous to simplify the skin 
models. The four-layer model was designed as a disk of 4-mm height and 30-mm diameter; this 
radial (lateral) extent of each layer was sufficient to be considered infinitely large compared to 












  The wavelength-dependent optical properties of the eight-layered model (absorption and 
scattering coefficients, scattering anisotropy, and refractive index) were extracted from multiple 
sources based on a review of the literature on tissue optical properties [62, 101, 102]. The optical 
parameters of the four-layer model were calculated as a weighted average by adding the products 
of the optical parameters of the eight layer model and the corresponding volume factors 
according to their volume contributions to each layer of the four-layer model [62, 103]. For 
example, the calculation for the optical parameters of deep dermis in the four-layer model can be 
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The optical properties of skin models and sensor models at each 4of the emission wavelengths 
(570nm, 585nm, 620nm, 635nm, 645nm and 665nm) were specified (Table 1) to track the 









Table 1 The optical properties for each layer of the four-layer skin model at each of the seven wavelengths 
used in simulation. 
 
SC+EP+Derm+UBP 






540 1.40 2.53 47.30 0.77 
570 1.40 2.41 45.76 0.77 
585 1.40 1.80 44.73 0.77 
620 1.40 1.35 42.70 0.77 
635 1.40 1.35 42.31 0.77 
645 1.40 1.36 42.02 0.77 
665 1.40 1.39 41.78 0.77 
Derm with 0.2% Blood 






540 1.40 0.55 46.01 0.77 
570 1.40 0.54 44.51 0.77 
585 1.40 0.48 43.01 0.77 
620 1.40 0.44 40.42 0.77 
635 1.40 0.43 40.27 0.77 
645 1.40 0.42 40.17 0.77 
665 1.40 0.41 40.02 0.77 
LBP+Derm 






540 1.38 9.12 47.10 0.83 
570 1.38 8.57 46.01 0.83 
585 1.38 3.48 44.92 0.83 
620 1.38 0.42 43.03 0.83 
635 1.38 0.40 42.92 0.83 
645 1.38 0.39 42.85 0.83 
665 1.38 0.37 42.74 0.83 
Subcutaneous Fat 540 - 665 1.46 - - - 








 The microsphere sensors were assumed to follow the previous work on micro-particle 
sensor engineering, where the spheres contain platinum octaethylporphine (PtOEP) and 
rhodamine isothiocyanate (RITC) as indicator and reference dyes, respectively [29, 30]. Briefly, 
glucose oxidase and PtOEP were immobilized inside of porous microparticles, which were then 
coated with diffusion-limited nano-films tagged with RITC as reference dye.  
 
The luminescence properties of the microsphere sensors are shown in Figure 7. The 
emission spectra were obtained in experiments. A green LED was used for excitation and a fiber-
optic spectrometer with a bifurcated fiber bundle was used to collect and measure emission. The 
emission spectrum of microparticles attached to a microscope slide within a flow-through 
channel was measured during exposure to phosphate buffers containing different glucose 
concentrations (flow rate: 4 mL/min; oxygen concentration: 277 (μM). Spectra collected at 0, 50, 
100, 150, and 250 mg/dL were recorded for use in this theoretical study. The absorption 
coefficient (11.16 mm−1) was calculated from the molar extinction coefficient of PtOEP at 540 
nm, assuming a uniform concentration of 10 nM inside the particles (determined 
experimentally), while scattering internal to the spheres was neglected [104]. A refractive index 
of 1.5 was assumed for the particles, based on their silicate nature. As the size of the particles is 
an experimentally controllable variable that affects sensor response as well as host response, this 
parameter was also varied in the simulations to reveal the effects of particle size on emission 
properties.  
 In this study, the implanted sensors are modeled as “patches” (Figure 8) comprising 
uniform microspheres positioned within the “dermis” of the four-layer model; the microspheres 
were assumed to be hexagonally packed into a cylindrical slab. In Figure 8, “D” is the sphere 
diameter and “S” is the center-to-center spacing. Since the particles could be engineered to have 
different size, and the in vivo packing density can be varied to a degree by controlling the 
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injection concentration, the diameters of microspheres and center-to-center spacing for adjacent 
spheres (Table 2) were varied from 20μm to 100μm to simulate the influence of these parameters 
on escaping emission signal. The real microparticle sensors have a certain size distribution, but 
the average size is around 20μm. Any spheres with smaller size may have a bigger possibility to 
be “eaten” by the cells (Phagocytosis). If the particles are bigger than 100μm, it injection needles 
might be clogged during injection. Thus, the sphere size was chosen between 20 and 100μm in 
modeling. The center-to-center spacing was varied to change the packing efficiency to loosely 
packed (0.5%) to tightly packed (74%). Table 2 shows that the sensor names in the simulations 
are D100S100, D60S100, D20S100, D60S60, D20S60, and D20S20, where the values following 
the “D” and “S” correspond to the diameter and the center-to-center spacing between two 
adjacent spheres for each case given below, respectively. It is noted that, in reality, one has very 
little control over the final particle distribution in tissue; however, the study was aimed at 
identifying the potential negative consequences of uneven or inconsistent distribution on 





Figure 7. Excitation and emission spectra of sensor particles, as well as spectral properties of a model light 
source (green filter). For the absorption spectrum shown, [PtOEP] is 10nM. Environmental [glucose] is 









































































Table 2 Geometric parameters of the six microsphere sensor models used in simulations 
 
D (μm) S (μm) Packing efficiency 
100 100 74.05% 
60 100 15.99% 
20 100 0.59% 
60 60 74.05% 
20 60 2.74% 




 The scheme of the modeling system is illustrated in Figure 8, including the geometric 
layout and the excitation source at normal incidence relative to the skin surface. Figure 8 
indicates the relative position of excitation light source, implanted fluorescent sensing 
microparticles, and photon capture film. The long pass filter below the photon capture film is 
block scattered excitation light. The distance between photon capture film and the surface of skin 
model is 10μm and that between long pass filter and the surface of skin model is 9.8μm. Though 
not shown this figure, the lateral extent of the skin model and the photon capture film (30mm) 
was much larger than the sensor patch size in all cases (1.2-6mm). The models of the 
microspheres were embedded in the skin model, thus the optical properties of the tissue 
surrounding and between the microspheres were the same as those of the skin model. Each 
sphere was modeled as an independent object, and the set of spheres was arranged into a 










 To simulate fluorescence emission escaping from the surface of the skin, one excitation 
wavelength (540nm) and six discrete emission wavelengths (570, 585, 620, 635, 645, and 
665nm) were selected from the excitation and emission spectra of sensors to capture the key 
features (as shown in Figure 7 of the excitation and emission spectra). In the simulations, 
excitation light underwent absorption and scattering while traveling through the superficial tissue 
before striking a sphere. Once the excitation photons enter a sphere, fluorescence occurs with 
isotropic directionality. The fluorescence inside a sphere was generated along each excitation ray 
according to a randomized distance, sampled from a uniform distribution with an average step 
size between fluorescence events that was specified as the radius of the sphere. The fluorescent 
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light emitted by a sphere, once escaped from the sphere, would undergo further absorption and 
scattering in the skin model. When rays were incident upon an interface between tissue and 
surface of another sphere, reflection occurred. Since the absorption coefficient of spheres was 
high, the fluorescence emission from a sphere tended to emit more from the surface than that 
emitted from the inner space. Moreover, since the excitation light came from the top of the skin 
model, the emission tended to be emitted more from the sphere surfaces close to the skin surface. 
The luminescent emission rays propagating through the skin model and finally escaping from the 
surface of the skin model were collected by a “photon capture film” detector, which recorded the 
energy and location information of every escaping ray hitting on the film. Below the photon 
capture film, an ideal long-pass filter was attached to remove all excitation light from the 
captured rays. The collimated excitation light source was perpendicular to the surface of the skin 
model and was placed directly below the long-pass filter. The photon capture film and the long-
pass filter were placed above the surface of the skin model. The distance between the photon 
capture film and the surface of the skin model was small enough to ensure the film would 
capture all the escaping rays.  Thus, the photon distribution on the film was an accurate 
representation of the predicted escaping photon distribution on the surface of the skin model.   
 
3.2.3 Study of excitation fluence distribution in skin 
To determine a reasonable dimension for 3D models of skin and microsphere sensors, the depth-
dependent spatial distribution of excitation fluence in skin model was investigated. The problem 
was broken into two parts: (1) Determining the irradiance distribution of a unit excitation light 
for different depths in tissue; and (2) Determining the circular areas which confine different 
fractions of unit excitation radiant power at different depths in the skin model. To study these 
two questions, the skin model was broken up into a series of sections with increasing thickness, 
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and a photon capture film was positioned at the bottom of every skin model section to capture all 
the exiting excitation light after undergoing absorption and scattering (Figure 10). The 
backscattering light reaching each depth from the deeper depth was not simulated in these 
models, because the excitation light hit the sensors from top to bottom, and the sensors would 
absorb most excitation light, thus there would be no such amount of backscattered light as that 
appearing when there were no sensors embedded in the skin model. In this situation, the 
refractive index of the skin model matched that of ambient to eliminate the total internal 
reflection. Thirty simulations were performed in triplicate for each of 30 different depths in the 
skin model, starting at 30μm (close to upper boundary of Upper Dermis) and moving to 2mm 
(close to the lower boundary of Deep Dermis). In each simulation run, 90000 rays were used. 





Figure 10.  Scheme of the modeling system for investigation of excitation fluence in skin. 
 
 
Skin model   (sliced 
into pieces) 
Photon capture film 
Excitation light 
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3.2.4 Investigation of sensor performance after implantation 
To investigate the potential to accurately measure changes in sensor implant spectral properties, 
the impact of the absorption and scattering of tissue, as well as the microparticle size distribution 
and concentration for different sensor models with different environmental glucose 
concentrations were studied. The emission spectra recorded from in vitro analysis of sensors at 
environmental glucose concentrations of 0, 100, and 250mg/mL (Figure 7) were used. 
Simulations were performed with the six output wavelengths (570, 585, 620, 635, 645 and 
665nm) weighted by the relative emission for different glucose concentrations. The ratios of 
emission intensity (I) of 645nm to that of 585nm were calculated from the output spectra of each 
sensor emission spectrum corresponding to each glucose concentration using the equation below.  
 
       ⁄ (   )  
    (       )
    (     )
 (20)  
 where Isen(645, C, t) is the emission intensity at 645nm of sensing dyes at the glucose 
concentration (C), and t is the time; Iref(585, t) is the emission intensity at 585nm of the reference 
dye, and it is irrelevant to glucose concentrations (C). The percentage change in 645nm/585nm 
emission peak ratios versus glucose concentration was calculated using the equation below: 
 
        [
       ⁄ (   )         ⁄ (   )
       ⁄ (    )
]       (21)  
where, t0 is the time when glucose concentration was 0mg/dL. 
 When glucose concentration was 0mg/mL, the 645nm/585nm emission peak ratio was 
defined as the baseline value. The percentage changes of peak ratios were plotted as a sensor 
response curve. Response curves for six different sensor models were compared. The diameter of 
the spheres was set to 100, 60, and 20μm, and the center-to-center spacing was set to 100, 60, 
and 20μm. The packing configuration of the sensor patch model was maintained at hexagonal 
 35 
packing and the total number of spheres was constant, as this would best represent the situation 
of injecting a fixed number of particles with different final distributions. All the sensor models 
used in this group simulation were one-layer versions, fixed at an implantation depth of 700μm. 
The light source was the 100μm×100μm square. There were two groups of simulations. In group 
A, the absorption coefficient (μa) of the microsphere sensors was scaled according to the volume 
of the spheres in order to make the product of μa and the volume of each sphere constant. In 
group B, the simulations for different glucose concentrations were repeated with a constant 
absorption coefficient (11.16 mm-1 @540nm) for all models. The simulation details were given 



























Group A Group B 







60 100 1459 4 51.67 1.0E+04 5 
20 100 1459 4 1395 1.6E+05 5 
60 60 1459 2.4 51.67 1.0E+04 5 
20 60 1460 2.4 1395 9.0E+04 3 
20 20 1462 0.8 1395 4.0E+04 3 
 
 
3.2.5 Investigation of measurability versus implant depths 
To implement in vivo measurement, it is possible that the implantation depths will be difficult to 
control with high precision; it is likely that particles will be distributed over different depths in 
the tissue. Thus, an assessment of measurability versus implantation depth is essential to 
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understand the potential quantitative impact of this practical issue on emission. For these 
simulations, a single layer of tight-packed sensors 100μm in diameter with 100μm center-to-
center spacing (“D100S100”) was used.  According to the assessment of spatial distribution of 
excitation fluence in skin model, the sensor patch was set to be 6mm in diameter (3260 spheres) 
to ensure the sensor patch size is much larger than that of the unit input light source (100μm
100μm square). This was verified as described in Section 2.4.1. The absorption coefficient at 
540nm of microparticle sensors was kept at 11.16mm-1. The depth of the sensor patch was varied 
from 400 to 1700μm, values representative of typical values for the upper and lower boundaries 
of the dermis layer. Fourteen simulations were performed for each of 14 depths over this range, 
and each simulation was repeated 3 times. 
 
 
3.2.6 Prediction of spatial distribution of escaping luminescence 
To design a highly efficient matched optical system for excitation delivery and emission 
collection, it is necessary to investigate the spatial distribution of the output signal. Using the 
simulation results for depth-dependent simulations with the 100μm×100μm unit light source in 
the previous section, 2D convolutions were performed to estimate responses to a large flat 
circular light source with the diameter ranging from 1mm to 10mm. Because the excitation light 
source needed a certain dimension in this CAD environment, and could not be simulated as an 
infinitely-small pencil beam in OptiCAD, the 1-D convolution method [105], which was mostly 
used in simulations for a finite incident photon beam, could not be applied in our simulations. 
Therefore, 2-D convolution, which is able to convolve a 2-D response, was performed with 
MATLAB to predict the spatial distribution of escaping luminescence responsing to incident 
excitation light sources with different sizes. 
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3.2.7 Assessment of absolute luminescence response 
To maximize the luminescence output and minimize the number of microparticles and amount of 
dye for in vivo implantation, it is critical to assess the fluorescent output for different sensor 
configurations and dye distributions. This task can be broken into three parts: (1) Investigating 
the impact of changes in sphere packing efficiency; (2) Assessing the impact on output due to the 
changes of dye concentration per sphere and effective dye concentration, given the same total 
quantity of dye; (3) Assessing the effects of having more particles in a stacked (layered) 
structure. The simulation details are summarized in Table 4. 
 For Step 1, the impact of sphere packing efficiency was investigated by varying center-
to-center spacing with a constant sphere size. Simulations were completed for three different 
one-layer sensor models with a sphere size of 20μm diameter, where center-to-center spacing 
was varied from 20μm to 100μm (D20S100, D20S60, D20S20).  In these simulations, the 
absorption coefficient of microparticle sensor models was fixed; thus, the effective dye 
concentration (the product of dye concentration per sphere and sphere packing efficiency (Table 
2)) decreased with decreasing sphere packing efficiency (increasing spacing). The maximum 
diameter of the sensor patches was 1.2mm, and the light source was a 2.4mm diameter uniform 
flat circular incident beam, ensuring all the sensor particles could be excited by excitation light. 
 For Step 2, the impact of dye concentration was assessed with all six sensor models 
(D100S100, D60S100, D20S100, D60S60, D20S60 and D20S20). The size of sensor patch 
models and the light source size were the same as those used in Step 1. The absorption 
coefficients of microparticle sensor models were scaled according to the volume of each sphere 
and particle numbers so as to make the product of the absorption coefficients, the volume per 
sphere and the particle number constant. Thus, each sensor model had the same quantity of dye 
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and the sensor models with the same center-to-center spacing have the same effective dye 
concentration. 
 For Step 3, effects of having more particles in a stacked (layered) structure were 
assessed with three different multilayer sensor models (D100S100, D60S100 and D20S100). In 
these simulations, all of the sensor patch models were 4mm in diameter and a unit input light 
source (100μm×100μm square) was used. The number of stacked layers of sensors was varied 
from one to three, and the absorption coefficients of microparticle sensor models were again 
scaled according to the volume per sphere. Thus, the product of absorption coefficients and 
sphere volume was constant, and the effective dye concentration in the tissue was constant for 





Table 4. Overview of simulations used to investigate sensor size/spacing/layer effects. Note: All of the  
sensor models in this series of simulations were located at the same depth (700μm). 
Sensor Model D20S100 D20S60 D20S20 D100S100 D60S100 D20S100 D60S60 D20S60 D20S20 D100S100 D60S100 D20S100
Sphere Diameter 
(D) (μm)
20 20 20 100 60 20 60 20 20 100 60 20
Sphere Packing 
Efficiency
0.59% 2.74% 74.05% 74.05% 15.99% 0.59% 74.05% 2.74% 74.05% 74.05% 15.99% 0.59%
Center-to-center 
spacing (S) (μm)
100 60 20 100 100 100 60 60 20 100 100 100
Number of 
spheres/layer
















































3.3 Results and discussions 
3.3.1 Excitation fluence distribution in skin 
Figure 11 is a plot of the predicted spatial distribution of the relative fluence of excitation light 
(relative fluence of excitation light that was normalized with incident light) in the skin model. 
The lateral diameter of skin model was 30mm and the diameter of excitation light source was 
100μm. The key point from this graph was that the beam spreads to cover a maximum cross 
section of a few millimeters, such that the sensor patch with 6mm diameter should be sufficient 
to ensure that the excitation beam did not exceed the path dimensions. As the light penetrated the 
tissue, the excitation intensity decreased from 10-2 to 10-8 from the upper boundary to the lower 
boundary of dermis layer, with an exponential decay following the expected profile.  This is 
more clearly revealed in Figure 12, which is a plot of relative power of excitation light versus 
depth. In each layer of skin model, the relative power plotted in log-scale decreased linearly with 
depth. 
Figure 13 is a plot of the radii for different fraction of total power at different depths, which 
is useful in understanding the lateral spreading of the light relative to the incident beam and 
sensor implant.  The 99.9% beam radii range from 0.71 to 2.44mm at the upper boundary and 
lower boundary of dermis, respectively, indicating that cylindrical models centered at the origin 
with diameter greater than 4.88mm can be considered as infinitely large compared with the size 
of unit light source. To ensure that the skin model and sensor models are infinitely large, 30mm 






Figure 12.  Simulation output for relative power of excitation light versus depth. Error bars (3 runs @ 




































Figure 11. Spatial distribution of relative irradiance (intensity) of excitation light in skin model. The 
color bar indicates the relative the relative intensity from 1 to 10-11. The green line at the origin 
indicates the green color of the light source. The light source is a uniform-intensity circle with 
diameter of 100μm. The thickness values for Upper Dermis, Dermis and Deep Dermis were 270μm, 






3.3.2 Sensor performance after implantation 
The simulated peak intensity ratios (645/585nm) versus glucose concentration were compared 
with those obtained from experiments in a flow-through system simulations.  The predicted peak 
ratio values were significantly higher than the in vitro measured values, due to spectral distortion 
introduced from absorption and scattering of tissue and sensors; specifically, the shorter 
wavelengths are attenuated more than the longer wavelengths. Figure 14 (a) and (b) showed the 
simulated peak ratios of 645nm to 585nm emission when the absorption coefficient (μa) of the 
microsphere sensors was scaled according to the volume of the spheres in order to make the 
product of μa and the volume of each sphere constant (group A in Table 3). Figure 14(a) and (b) 
 
Figure 13. Radius of excitation areas with different fraction of total excitation power versus depth. 
The light source considered in theses case was a circle with diameter of 100μm. 
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showed the simulated peak ratios of 645nm to 585nm emission when absorption coefficient was 
kept as an constant at 11.16 mm-1 @540nm for all sensor models (group B in Table 3). 
 However, when considering the need to measure changes in emission and correlate those 
with biochemical changes in the sensor environment, it is the percentage change in the peak ratio 
with analyte concentration that is most relevant. The percentage change of peak ratios was 
calculated as in Equation (25). The simulated percentage changes of peak ratios were shown in 
Figure 15 and 16. Figure 15 (a) and (b) were the results of simulations of group A (Table 3), and 
Figure 16 (a) and (b) were the results of group B(Table 3). From Figure 15 and 16, it is clear that 
all the data fall around the same in vitro curve.  Figure 15(b) and Figure 16(b)  are a statistical 
analysis of Figure 15(a) and Figure 16(a), where each of the 95% confidence intervals include 
the corresponding calibration curve (in vitro curve) value, with the single exception of the small 
spheres with small spacing (tight packing, D20S20) at 250 mg/dL. This proves that the changes 
in emission will be essentially identical to those observed in vitro, enabling direct application of 
in vitro calibration with single-point correction, without additional significant effects from 
apparently strong spectral distortions. The single case of statistically different output indicates 
that the spectral distortion introduced by the tissue will require a new calibration model to be 







Figure 14. (a) Peak ratios of 645nm to 585nm emission when the absorption coefficient of sensors was 








Figure 15. (a)  Peak ratios of 645nm to 585nm emission when the absorption coefficient of sensors was 










Figure 16. (a) Percentage changes of peak ratios (645/585) when the absorption coefficient of sensors was 









Figure 17. (a) Percentage changes of peak ratios (645/585) when the absorption coefficient of sensors was 
constant (group B in Table 3). (b) statistical analysis of (a). Error bars are 95% confidence invertal. 
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3.3.3 Effects of varying implantation depths 
The predicted emission spectrum from implanted sensors versus the implantation depths is given 
in Figure 18.  As shown in this graph, the relative intensity decreases as the implants are located 
deeper in tissue. The ratio of total escaping fluorescence power to that of the total excitation 
power is also shown in Figure 19 [106], from which it can be observed that the ratio of output 
power (fluorescence emission light escaping from the skin surface) to the input excitation power 
ranges from 10-3 to 10-6 for sensors at the upper and lower boundaries of the dermis (400µm and 
1700µm from the skin surface, respectively). Therefore, the efficiency of fluorescence ranges 
from approximately one photon per 1000 input photons to one photon per 1,000,000 input 
photons.  On a practical level, this means that a 1mW excitation light source with 1mW/mm2 
input intensity the expected minimal output intensity is 1nW. Thus, the output should be 
detectable using common detectors such as avalanche photodiodes or photomultiplier tubes, 
regardless of implant depth. It is noteworthy that the maximum permissible exposure (MPE) for 
human skin is given as 2mW/mm2 [107], and therefore these numbers are realistically 
achievable.  
 The peak ratios values for the emission (645/ 585nm) versus implantation depth are 
given in Figure 20. In this graph, the peak ratios increases slightly as the sensor goes deeper, this 
is mainly because the shorter wavelength is absorbed more than longer wavelength since 585nm 
is close to one of the absorption peaks of hemoglobin. This observation has two important 
implications for our work. First, the peak ratio is not very strongly dependent on depth, such that 





Second, the peak ratio does significantly increase relative to the value expected without tissue, 
indicating that the measurements could be susceptible to fluctuations in optical properties of 
tissue superficial to and in between sensor particles.  For example, changes in hemoglobin 
saturation will alter the absorption of light emitted by sensors at 585nm, which would 
subsequently change the corresponding measured intensity ratio.  It is worth mentioning that 
these sensors could monitored with luminescence lifetime analysis, which would rely on the 
emission from the longer-wavelength oxygen-sensitive porphyrin (645nm for PtOEP, or 700nm 
if the palladium version of the same molecule is used); in this case, varying attenuation due to 
tissue would have even less influence on measured signals due to the longer wavelength and the 
inherently robust nature of lifetime analysis. Thorough consideration of factors such as skin 
color, dynamic chromophore concentration changes, oxygenation shifts, and scattering increases 
due to formation of a fibrous collagen capsule around the implants will be given in future 
studies; however, the focus of this work is on studying the effects of sensor configurations, 




Figure 18. Spectrum of escaping fluorescence relative input light at different sensor implantation depth.  
The log scale intensity axis highlights the exponential depth dependence. The sensor configuration was a 




Figure 19. Ratio of total escaping fluorescence power to the total input excitation power versus depth. 
Inset is log-scale plot. The environmental glucose concentration used for emission spectra was 250mg/dL 
(the spectra obtained from prototype sensors exposed to 250mg/dL in vitro were used). The absorption 































3.3.4 Spatial distribution of escaping luminescence 
Figure 21 is a plot of the spatial distribution of relative integrated escaping power versus 
distance from the center of the light source. As shown, the integrated output power increases 
quickly with distance, which illustrates that the emission output power drops rapidly with 
distance from the light source center (origin). However, for the 1mm radius light source, the 
scattering of light in the tissue results in continuing increases in emission beyond the edges of 
the input beam.  The escaping photons become more broadly distributed as the implantation 
depth increases. In all cases, at least 50% of the total integrated output power is confined within 
a circular area with 2 mm radius.  When the goal is to capture 90% of the output light, the 
required capture radius increases to 1.5-5.0 mm, depending upon the implant depth.  Similarly, a 
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 Figure 22 contains a surface plot, where the surface height represents the radius for a 
circular area that confines 95% of total escaping fluorescence power collected on the photon 
capture film. The surfaces were computed for different implant depths as well as different light 
source diameters.  It can be seen that, even for a light source with 10mm diameter and sensors 
implanted close to the lower boundary of dermis, a circular area with a radius of 9mm was able 
to confine 95% of total output power.  Thus, in general, deeper implants require larger field of 
view for collection optics to avoid throwing away photons, but efficient collection of output for 
dermal implants can still be achieved with relatively small-area optics; a standard 1-inch optical 
system will be sufficient. 
 
 
Figure 21.  Spatial distribution of integrated power versus implantation depths. (Excitation light source 
size = 2mm in diameter). The discrete color data points of different colors represent different fraction of 
















































Figure 22.  Radii of circular area confining different fraction of total escaping fluorescence power versus 
implantation depths and size of excitation light source. 
 
 
 Since the angle of escape and numerical aperture of the optics involved will also 
determine the efficiency of collection, I also investigated the angular distribution of escaping 
fluorescence versus different implantation depths (data not shown). The angle of escape was 
found to decrease linearly with cos(θ) (matches Lambert’s cosine law), and therefore high-
numerical aperture optics are desirable for capturing emission.  There was no significant effect 
of implant depth on angular distribution (p-value = 1.0, α=0.05, paired t-test).  Thus, the spatial 
distribution of escaping fluorescence is the most critical factor of optical system design. 
 
3.3.5 Absolute luminescence response 
Figure 23 contains a plot representing the results of Step 1 (Table 4) simulations used to 































































simulations, the dye concentration per sphere was kept constant (bold numbers in the column of 
Step 1 in Table 4), meaning that the effective concentration of dye in the tissue decreased with 
lower packing efficiency. Intuitively, one would expect the fluorescence output per sphere would 
be reduced by less sphere packing efficiency because of relatively more absorption induced by 
tissue; however, it is evident from these results that the output per sphere for the D20S20 sensor 
model is smaller than those of D20S60 and D20S100, even though the total output of D20S20 is 
the largest. This is attributed to a higher probability of interaction between laterally scattered 
excitation light and particles in loosely-packed (center-to-center distance = 60 or 100μm) sensor 
models or the lower probability of re-absorption by loosely-packed spheres. Accordingly,  the 
D20S60 and D20S100 sensor models will have more output than that of D20S20, if the three 
sensor models have the same number of spheres and the light source is large enough to ensure all 
the spheres are uniformly excited. Thus, if a large enough light source is used to uniformly excite 
all the particles regardless the particle spatial distribution, a lower sphere packing efficiency will 





Figure 23. Normalized output for sensor models with different packing efﬁciency, including total output 




In reality, implementation of in vivo injections will result in difficulty of controlling the 
implantation area with high precision; it is also likely that particles will be distributed with 
different projection areas in the tissue, thus a sufficiently large light source with constant 
irradiance is preferred to avoid reducing fluorescence output due to the unpredicted projection 
area change of injected sensors in tissue. 
Figure 24 contains the results of Step 2 (Table 4), where six different sensor models were 
used to assess how different dye concentration per sphere and effective tissue dye concentration 
affect the escaping fluorescence, given the same quantity of dye (see bold numbers in the column 
of Step 1 in Table 4). As shown in this graph, though every sensor model had the same total 
amount of dye in the entire patch of particles, the output is dramatically different. The output 
from tightly-packed models (D100S100, D60S60, and D20S20) was higher than that from 
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per sphere of D100S100 is the smallest and that of D20S100 is the highest. According to the 
simulation results, the tightly-packed sensors produce stronger signals than loosely-packing 
sensors, even when the amount of dye in the sensor patch remains constant. The average output 
per sphere of loosely-packed spheres (empty symbols) were higher than that of tightly-packed 
models, which again proved that the loosely-packed sphere models have a lower inner filter 
effect than the tighter-packed versions. Since these sensor models had the same amount of dye, 
the ones cases having the same effective dye concentration should produce the same amount of 
luminescence emission as if the sensor was a homogeneous model. Though the effective dye 
concentration of “D100S100”, “D60S100” and “D20S100” were all 1.28nM, the estimates for 
total output power of these models were not the same.  Neither were the outputs of “D60S60” 
and “D20S60,”which also had the same concentration. This highlights the inadequacy of a 
homogeneous model, a fact that was previously discussed in the context of discrete absorbers for 




Figure 24. Relative output for different sensor models. All the sensor patches were 1.2 mm in diameter, 
and the uniform light source was 2.4 mm in diameter with intensity of 1 mW/mm2. The absorption 
coefﬁcients of D100S100, D60S100, D20S100, D60S60, D20S60, and D20S20 were 1.93 mm−1, 8.92 




 Figure 25 contains the results of simulations for Step 3 (Table 4), designed to assess the 
effects of multiple layers of microparticles (see Table 2).  One to three layers of D100S100, 
D20S100 and D20S100 sensor models were used, and all the sensor models have the same 
effective dye concentration (Table 4). The output of 2-layer D100S100 and 3-layer D100S100 
are 20.3% and 20.9% higher than that of 1-layer D100S100, respectively. The output of 2-layer 
D20S100 and 3-layer D20S100 are 47.5% and 75.5% higher than that of 1-layer D20S100. 
Interestingly, while adding more layers to tightly-packed sensor models does not increase 
fluorescence output as much as loose-packing sensor models, the output of just one layer of 
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the tighter the particles are packed, the less sensitive to changing number of layers and the higher 




Figure 25. Output for different sensor models with different numbers of layers. Light source is 100 m100 
m square with intensity 1mW/mm2. The absorption coefﬁcients of D100S100, D60S100, and D20S100 
were 11.16 mm−1, 51.67 mm−1, and 1395 mm−1, respectively. Models with the same number of layers had 




 In summary of this phase of the work, the simulation results corroborate our 
experimental efforts in highlighting that tight packing is preferred for maximal signals.  That is, 
when the total quantity of dye is limited, if concentration per sphere is already maximized and 
given a fixed light source size, the sensors with high packing efficiency is always preferred, 
because sensors with high packing efficiency can yield higher output with fewer particles 
compared with sensors with smaller packing efficiency. 
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Three-dimensional, multi-wavelength simulations of light interaction with tissue and 
luminescent materials have enabled us to gain insight into the expected behavior of implantable 
biosensors.  The simulations described here reveal key factors influencing the generation and 
collection of fluorescence from sensors implanted in the dermis at different depths and 
concentrations, which provides critical information for future work in instrument design. The 
simulation results show that the depths of implantation strongly influence the measurability of 
signal. The deeper the sensor is located, the more the signal is attenuated.  With strong scattering 
and absorption of both excitation and emission light due to overlying tissue, the predicted ratio 
of output to input power ranges from 10-3 to 10-6; and the signals generated from implants should 
be detectable at all depths within the dermis using sensitive detectors. The assessment of the 
spatial distribution of escaping fluorescence also provides useful information; it was found that 
95% total signal (escaping fluorescence), even when excited with a 10mm diameter light source 
can be confined within a circular area on skin surface with diameter smaller than 18mm, which 
facilitates design of a matched optoelectronic system for efficient delivery of excitation, 
collection and analysis of luminescence response. Analysis of fluorescence output of different 
sensor configurations also indicates that the tightly-packed sensors are preferred because they 
yield higher fluorescence output with fewer particles.  Thus, it is preferred to implant particles in 
a single site with high concentration.  If the light source size can be varied with constant 
irradiance, a large light source is preferred to overcome the influence of unpredicted projection 
area change of implanted sensors in tissue. However, it is hard to control the particle distribution 
during implantation, and even though the tightly packed particles can yield more luminescence 
output, there are still other factors affecting the luminescence. For example, if the particles are 
packed densely, the space between particles for diffusion of blood glucose or oxygen may not be 
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enough for the sensors’ response. Taking into multiply factors into consideration, if the highest 
dye concentration per sphere is achievable, moderately high particle concentrations for injection 
is desirable. The results of simulations to predict sensor in vivo performance show that the 
spectral distortion resulting from the absorption and scattering of the skin, particle size, or 
particle concentrations has minimal influence over the predicted ratiometric measurements. The 
focus of this work was to determine the effects of sensor configurations, implant depths, and 
excitation beam characteristics on the intensity, spatial and spectral distribution of escaping light. 
However, it is acknowledged that many practical questions regarding other factors that may also 
perturb the optical signals must also be answered before monitoring can be considered realistic.  
These include, for example, investigation of the influence of changes in blood volume, 
hemoglobin concentration and saturation, oxygenation shifts, and scattering increases due to 
formation of a fibrous collagen capsule around the implants.  
 In all, this simulation work supported the potential to accurately measure the output of 
luminescent implants and facilitated the design of a simple optical hardware system to 
communicate with dermally-implanted sensors. The purpose of the research in Section 3 was to 
investigate the photo transportation and interaction with implanted sensors. The results predicted 
the output signal after implantation, which facilitated the optical design in Section 4. The 
hardware design in Section 4 was based on the results in this section. These results not only 
could facilitate the hardware design for our dermally-implantable microparticle luminescent 




4. DESIGN AND EVALUATION OF AN OPTICAL SYSTEM FOR SENSOR 
INTERROGATION* 
 
4.1 Significance and background  
To deploy and interrogate luminescence-based dermally implanted sensors in vivo for on-
demand monitoring, it is necessary to design a matched optoelectronic system to interrogate our 
dermally-implanted microparticle sensors. It needs to be of high efficiency to deliver excitation 
light, collect luminescence, and measure luminescence. A bifurcated optical fiber bundle is 
commonly used to deliver excitation light and to collect luminescence from a scattering medium, 
but the excitation and collection efficiency is limited due to the numerical aperture and size 
limitation. In order to enlarge the probe size, a customized fiber bundle with hundreds fibers are 
used, but it is still costly, and the collection efficiency is still limited because locations for 
delivery of excitation light and those for collection of luminescence are separate, thus it is 
inevitable to lose luminescence coming from where excitation light goes in.  To our knowledge, 
there is no commercial product or research report of a hardware design with high efficiency that 
is suitable for interrogation of dermally-implanted luminescence sensors. The aim of this chapter 
is to develop a hardware system that will overcome the shortcomings of current bifurcated 
optical fiber with respect to excitation and emission collection efficiency. 
 To evaluate the designed system while minimizing animal use, an evaluation phantom is 
needed. Thus, a stable and repeatable skin phantom mimicking optical properties of human skin 
is necessary to develop. Because of the stability and repeatability of the phantoms, they are 
useful in 1) initially testing system designs; 2) facilitate optimization of signal to noise ratio in 
existing system; 3) performing routine quality control; 4) comparing performance between 
system.[108] The history of tissue-simulating phantoms for optical diagnostic system began in 
*Part of this section is reprinted with permission by R. Long, B. Collier, J. Roberts, and M. 
J. McShane, 2010, Proc. SPIE 757205, Copyright [2010] SPIE. 
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the early 1980s with the surge of clinical interest in near-infrared trans-illumination for breast 
cancer imaging [109-112]. Later interest rose from applications in photodynamic therapy and 
pulsed laser treatment [113-118].  In the early 1990s, generation of various types of tissue 
phantoms was spurred due to the introduction of spatially-resolved, time-resolved, and 
frequency-domain spectroscopy and imaging techniques. [119-124] In recent years, the 
applications of light in medicine have increased rapidly, since cosmetic laser surgery is a major 
commercial driving force. The research on tomography [125-130], photodynamic therapy, [114, 
118, 131], etc, keeps the development of tissue-simulating phantom processing and important.  
      
4.2  Methods 
The aims of the hardware system design were 1) efficient delivery of excitation photons; 2) 
numerical aperture as large as possible (0.5~0.9) to obtain high collection efficiency; 3) compact 
size. 
 
4.2.1 Hardware design 
The hardware system for delivery of excitation light and collection of luminescent light was 
designed based on the results of modeling work, which was performed in the last section. The 
hardware system was consisted of the components to deliver excitation light, collect 
luminescence, and couple light into a commercial spectrometer. The measurement of spectrum 
of luminescence was performed with the commercial spectrometer. The aim of the system design 
is to overcome the shortcoming of bifurcated fiber bundle. Figure 26 is a scheme of the hardware 
design. The green LED was the excitation light source, since the sensors absorb green light 
strongly. Even though the sensors absorb light with shorter wavelength (such as UV) more 
strongly, the UV tends to denature the enzyme inside the sensors, and it is easier for the skin to 
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get burnt from UV light. Thus green light was chosen as excitation light source. The green LED 
light was collimated through a lens and delivered onto the dichroic mirror, and it was reflected 
by the dichroic mirror and focused onto the skin surface. The excited luminescent photons 
escaped from the skin surface and then were collected by the optical system. The luminescent 
light was collimated and went through the dichroic mirror and finally coupled into the 
spectrometer. In order to maximized the collection efficiency, which is defined as the ratio of 
luminescent photons collected by the system to the total luminescent photons escaping from the 
skin surface, modeling work were performed with OptiCAD to analyze the collection efficiency 




Figure 26.  Scheme of modeling system for hardware design 
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 In modeling, lens models were imported from the lens catalogue of OptiCAD, if using 
commercially available lenses. If not, lens models were designed according to the desired 
parameters. However, in order to reduce the cost, off-the-shelf lenses were preferred, unless a 
customized lens would greatly enhance the performance. Filters and mirrors were modeled as 
100% transmittance or 100% reflectance initially to simulate an ideal situation. Sensor model 
and skin model were close to the real dimensions that would be used in experiments. The total 
escaping luminescent photons were recorded with the transparent film (I) (Figure 22) covering 
the surface of the skin model. The total luminescent photons collected by the hardware system 
were recorded with the transparent film (II) in the middle of Figure 22. Thus, the collection 
efficiency was equal to the ratios of the photons collected by the transparent film (II) to those 
collected by the film (I). The collection efficiency was optimized by varying lens position and 
lens shape until it reached maximum. The design criteria of the hardware system are 1) high 
interrogation and collection efficiency; 2) compact; 3) use off-the-shelf optics as many as 
possible to make it cost-effective. Interrogation efficiency is the ratio of the input excitation light 
power to that of luminescent photons collected with the hardware. Collection efficiency is the 
ratio of total escaping luminescence to that collected by the hardware. Though the interrogation 
efficiency depends on the implantation depths, optical properties of skin (phantom), and the size 
and concentration of the sensors, it was compared under the same conditions.  
 To evaluate a designed hardware system, evaluation medium is needed. In order to 
minimize the animal use, a skin phantom that matches the optical properties of skin is desirable 
for the experimental evaluation.  
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4.2.2 Development of evaluation phantom 
A silicone based phantom was made to meet the criteria for our purposes (1) matching the 
optical properties of skin; (2) stable; (3) easily moldable; and (4) suitable for use in the dynamic 
test apparatus. The skin phantom would be used as an upper layer covering the sensor patch 
immobilized on a microscope glass slide to test the capability of the optical hardware during in 
vitro static test and then it could be used in a flow chamber system for later dynamic in vitro test. 
The anatomy structure of skin varies in different types and depends on the location of skin. 
Optical properties also vary in skin structure, age, color, body temperature, blood perfusion and 
locations. Moreover, the published optical properties of skin varied as well, particularly 
(reduced) scattering coefficients. Therefore, the goal was to make a skin phantom that 
sufficiently matches the highest values of published optical properties so as to present the worst-
case scenario in terms of attention. If our hardware system is capable of detecting luminescent 
signal of sensors propagating through the developed phantoms, it should be sufficient to be 
moved forward into animal experiments and clinical tests. 
 
4.2.2.1 Recipe design 
Optical properties (μa, μs, g) of skin are dominated by epidermis and dermis [102], because 
absorption coefficients are mostly dependent on volume fraction of melanosomes in epidermis 
and cutaneous blood perfusion in dermis, while scattering coefficient and anisotropy factor (g) is 
dominated by dermis layer due to its big volume fraction in skin. Therefore, the extracted optical 
properties from publications were the averaged optical properties of epidermis and dermis layer 
according to their volume fraction in skin. To calculate average optical properties, the thickness 
of epidermis (100μm) and dermis (1900μm)  are referred [62].  
 65 
 The main component of phantom is silicone elastomer base (SYLGARD® USA). 
Refractive index of silicone elastomer (1.410~1.414) [132] is similar to that of soft mammalian 
tissue (1.33-1.50) [133]. The main absorbing material used to mimic the main absorption 
attributes over excitation and emission range of our sensors (500nm-700nm) was cosmetic 
powder (Color Genius Pressed Powder, Deep Beige, Max Factor, Italy) [134]. Red ink (DESIGN 
Higgins®, SANFORD) was used as additional absorber to mimic the absorption properties of 
oxygenated blood.  The scattering agent was Aluminum Oxide (Al2O3) powder (<10μm 99.7 % 
metals basis, Sigma Aldrich®).  
 The target μa is the volumetric average μa of skin based on a seven-layered skin structure 
[24]. The absorption coefficients of stratum corneum (10μm), epidermis (80μm), three dermis 
layer (100,1500, and 160μm), upper blood plexus (10% dermis and 90% blood, 80μm [24]) and  
deep blood plexus (90% blood and 10% dermis, 70μm [24]) were extracted from Van Gemert’s 
paper [25] except the properties of blood which was extracted from [26].  All the absorption 
coefficients were averaged according to their volume fractions [20, 24, 27]. Because the 
absorption coefficients are mostly dependent on volume fraction of melanosomes in epidermis 
and cutaneous blood perfusion in dermis, the absorption coefficient (μa) of skin is dominated by 
epidermis and dermis [25]. The absorption spectrum (Figure 27) of red ink diluted by a factor of 
5000 in deionized water and  attenuation spectrum (Figure 27)  of 1mg cosmetic powder diluted 
in 2mL silicone elastomer and cured for one hour at  70◦C were measured by a spectrometer 
(USB 2000, Ocean Optics Inc.). Attenuation coefficient of the cosmetic powder used was close 








Figure 27.  Absorption spectra of red ink (0.02% in deionized water) and attenuation spectra of cosmetic 
powder (1mg per 2mL silicone base) and error bars are one standard deviation. The solid circles are 






 The target μs or μs’ were the volumetric average of μs’ of epidermis (100μm, Wan et al 
[29]) and dermis (1900μm , Anderson et al [30]). Because μs’ directly affects the effective 
attenuation coefficient (μeff2= 3μa×( μa+ μs’) ), the reduced scattering coefficient (μs’ = (1-g) × μs) 












































knowledge, the highest reduced scattering coefficients of epidermis and dermis were calculated 
from Wan et al [29] and Anderson et al’s [30] results of absorption parameter (K) and scattering 
parameter (S) of Kubelka-Munk model obtained from integrating sphere measurements, 
respectively. Conversion of Kubelka-Munk parameters (K and S) to absorption and reduced 
scattering coefficients (μa and μs’) was using μa =ηK, and μs’= χS as the method in ref [25]. The 
thickness of epidermis for the calculation of volumetric average was 100μm and that of dermis 
was 1900μm [28]. Because the μs and μs’ are dominated by dermis layer due to its big volume 
fraction in skin, most of the optical properties extracted from publications were the averaged 
optical properties of epidermis and dermis according to their volume fraction in skin. The 
concentration of Al2O3 powder in uncured elastomer base was predicted using Mie theory [31]. 
The scattering coefficient of Al2O3 powder in uncured elastomer base was calculated using Mie-
theory assuming all the Al2O3 particles were uniform spheres with diameter 5.612μm that was 
the mode particle size of Al2O3 powder. Table 5 shows the parameters used in Mie scattering 
calculation and the calculated results [135]. The sphere concentration was 1.43×10-3 spheres/μm3 
and all the imagine index of refraction were 0 and number of angles was 200 in calculations, and 
Mie scattering calculation were carried out with online calculator [135]. The difference of 














 The final recipe of skin phantoms was settled to be 97.7mg Al2O3 powder, 12.66mg 
cosmetic powder, 1.67μL red ink in every 1mL silicone elastomer base (SYLGARD® USA).  
 
 
4.2.2.2 Procedure of phantom fabrication 
Al2O3 powder, cosmetic powder, and red ink into silicone elastomer base were mixed according 
to the recipe. The mixture was sonicated and stirred until homogeneous and then curing agent 
was added at 1:10 volumetric ratios of agent to base. The resulting mixture was stirred and cast 
into 34mm diameter molds (plastic Petri dishes) or spread onto a glass slide to achieve thinner 
phantom. After applying vacuum to remove bubbles in the mixture, the samples were cured at 
70◦C for one hour in an oven. The thickness of phantoms ranged from 30μm to 1.8mm which 
was varied by dispensing different uncured elastomer volume into molds or applying pressure on 
two glass slides to sandwich uncured silicone mixture. 
540 1.41 1.77 13.25 11.10 11.20 10.32 7.87%
570 1.41 1.77 12.75 10.22 10.35 9.68 6.41%
585 1.41 1.77 12.69 9.85 9.99 9.32 6.74%
620 1.41 1.77 12.38 9.18 9.34 9.44 -1.06%
635 1.41 1.77 12.13 8.98 9.13 9.19 -0.61%
645 1.41 1.77 11.94 8.86 9.02 10.72 -18.84%

























4.2.2.3 Determination of optical properties 
The absorption coefficient (μa), reduced scattering (μs’), scattering coefficient (μs), and 
anisotropy factor (g) of cured skin phantoms were determined by integrating sphere (IS) 
measurement systems (Figure 24) and Inverse Adding-Doubling (IAD) software package (v 
3.5.10, 11 May 2009) [136]. Total diffuse reflection (R) and diffuse transmission (T) were 
collected by the integrating sphere, and were spectrally analyzed with a grating-CCD 
spectrometer (USB 4000, Ocean Optics, Inc.). There two approaches of integrating sphere 
measurements: single-sphere and double-sphere. The single sphere means that one sphere is used 
at a time for diffuse reflectance or transmittance measurement, and two-sphere means that two 
integrating spheres are used at a time to measure reflectance and transmittance simultaneously. 
There are pros and cons to use two spheres. If the sample’s optical properties change 
dynamically, then it is important to measure reflectance and transmittance simultaneously. 
However, it is difficult to make good contact on both sides of the samples with the two spheres, 
and it is hard to make the sphere calibration for the two-sphere system [137]. Because skin 
phantoms are of good thermal and chemical stability, it is not necessary to measure reflectance 
and transmittance simultaneously. Thus single-sphere measurements were performed. Spectrum 
of collimated (unscattered) transmission (U) was measured with setup shown in Figure 25. A 
pinhole (Thorlabs, Inc) was used to confine acceptance angle. Detector port (port 2 in Figure 24) 
of integrating sphere was connected with the spectrometer via a fiber (1mm core and 0.5 NA). 
Parameters of the integrating sphere (Labsphere®, North Sutton, New Hamsphere) were as 
follows:  sphere diameter = 101.6mm; diameter of sample port (port 3 in Figure 2) = 12.7mm; 
diameter of entrance port (port 1 in Figure 26) = 12.7mm; diameter of detector port (port 2 in 
Figure 26) = 1mm, reflectivity of inner wall = 96%. The light source was Tungsten halogen light 
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source (LS-1, Ocean Optics, Inc.) emitting light collimated by a collimating lens (F220SMA, 
Thorlabs, Inc.). All the samples were sandwiched between two 1mm-thick microscope glass 
slides. IAD is a method to calculate optical properties of a sample by iteratively solving the 
radiative transport equation until the solution matches the input values of diffuse reflectance 
(MR), diffuse transmittance (MT) and (if desired) collimated transmittance (MC) [138] that were 
calculated from measured R, T, and U.  
 For measurements of diffuse reflection (R), the light source was placed at the entrance 
port (port 1 in Figure 26) and sample was placed at sample port (port 3 in Figure 26). Integration 
time of the spectrometer was 1 second and the dark background spectra were subtracted in all 
measurements. The collimated illumination beam formed a spot 6mm in diameter on a sample. 
Because the distance from the edge of the illumination beam on the sample to the edge of sample 
port was 3.35mm that could be considered much larger than the lateral light propagation distance 
which was determined by 1/(μa+μs’) ≈ 1/( 0.5+8) ≈ 0.118 (mm), then relatively little light  should 
be lost out the side of the sample [139]. 10% and 50% reflectance standards (SRS-10-010, SRS-
50 010, Labsphere®, North Sutton, New Hamsphire) (R=10% and R=50%) were used to get 
reflection spectra (R10% and R50%) for calibration. Then diffuse reflectance (MR) was calculated 
using the equation below: 
 
   
      
         




 For diffuse transmission (T) measurement, the collimated light source was placed in 
front of the sample port (port 3) forming an illumination spot on a sample with diameter of 6mm 
again. Integration time of the spectrometer was 1 second, and dark background spectra were 
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extracted in all measurement, as well. The entrance port (port 1 in Figure 28) was blocked. Then 
diffuse transmittance (MT) was calculated using equation as below:  












 For collimated (unscattered) transmission (U) measurement (Figure 29), a pin hole 
(Thorlabs) with diameter of 0.86mm was placed in front of the spectrometer to limit the 
acceptance angle to 0.16◦. Spectra of unscattered transmission (U) were collected by the 
spectrometer via optical fiber 3 (400μm core and NA 0.37) (Figure 25) coupled to the 
 
Figure 28. Scheme of integration sphere system to measure optical properties of skin phantoms 
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collimating lens 2 (Thorlabs) attached to the pinhole. Collimated transmittance was calculated 
using equation below: 






U is the spectrum of unscattered transmission of a sample and U0 is the transmission spectrum 












 Some samples were too thick to get a reliable signal, to make sure the collimated 
transmittance are reliable, collimated transmittance was plotted versus the sample thickness to 
check if this line was exponentially decreasing versus sample thickness. Input of diffuse 
reflectance (MR), transmittance (MT) and collimated transmittance (MC) (three-measurement) in 
IAD calculation would yield absorption coefficients (μa), reduced scattering coefficients (μs’= 
(1-g) × μs) and anisotropy factor (g), so scattering coefficient (μs) could be calculated according 
to μs’ and g. Input of only diffuse reflectance and transmittance would yield only absorption 
coefficients (μa) and reduced scattering coefficients (μs’) from “two-measurement” calculation in 
IAD. 
 After the skin phantoms were developed, the simulations and experimental evaluations 
for the developed hardware system and the skin phantoms were performed to validate the 
accuracy of the developed phantom, and the simulations including Monte Carlo modeling and 
geometric ray-tracing for the system. 
 
 
4.2.3 Simulation system 
Simulations were performed using OptiCAD® (v10.046). The simulation system (Figure 30) 
modeled all the optics needed. All 1-inch spherical lens models were imported from the lens 
catalog of OptiCAD®. The models of aspheric lens were downloaded from the lens company’s 
website as CAD files and imported into OptiCAD. Refractive index of glasses of lenses was 
imported from the source material of OptiCAD®. Aspheric lens models were tested in 
OptiCAD® with glass material applied in all cases, and the simulated focal lengths matched 
those reported in product data sheets. The simulations considered one excitation (540nm) and six 
emission wavelengths (570, 585, 620, 635, 645 and 665nm). The emission spectrum used in 
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simulations was collected when the sensors were exposed to air. As shown in Figure 26, the 
“photon capture film” was used as a “detector” to capture luminescent emission photons which 
would be collected by the optical fiber (NA=0.37, core diameter = 400μm). The size of the 
photon capture film and distance to the optical fiber confined the entrance numerical aperture to 
0.22 that was the same as the commercial spectrometer used in experiments. A tube was 
positioned outside the aspheric lens to block the laterally reflected luminescent emission 
photons. The emission angle of the light source was shaped as a 60° cone. A homogeneous 
phantom model was created and the optical properties of phantom model were the values 
determined by integrating sphere measurement and IAD calculation. The refractive index of 
silicone elastomer for the six wavelengths (540, 570, 585, 620, 635 and 645nm) used in 
simulation was determined by using the equation below  [132]. 






 (25)  
 
where, A = 1.399249923, B = 6.19643289×10-3, C = -5.2646592×10-4, λ is wavelength in 







Figure 30. Scheme of simulation for the optical system. The photon capture film was used to model the 
detector situated at the position of the collimating lens in the spectrometer that confined the entrance 




 Microparticle sensor patch was modeled as a cylindrical slab with 3mm in diameter and 
20μm high to mimic the dimension of sensor patch we used in experiment. Because the 
microparticle sensor samples were covered by a skin phantom but not embedded in skin phantom 
and the microparticles were dried and condensed packed, a homogeneous slab model should be 
sufficient to model in vitro situation. The absorption coefficient of sensors was calculated from 
the molar extinction coefficient (11.16mm-1) of sensors fabricated containing platinum 
octaethylporphine (PtOEP) and rhodamine isothiocyanate (RITC) as indicator and reference 
dyes, respectively [30]. Simulations were carried out for phantom models with different 
thickness to compare the results obtained from experiments. 
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 Simulations of bifurcated fiber bundle (Figure 31) used previously were performed as 
well. The fiber bundle model is an approximation of the real fiber bundle used, since the 
excitation fibers and emission fibers were not randomly distributed as that of real fiber bundle. 
Other than that, fiber bundle model has the same parameters. The light source is shaped as a 25° 
cone to match the numerical aperture of fiber bundle that is 0.22. In figure 24, the photon capture 
film is attached at the end of emission fibers to collect photons delivered by the fibers. Covering 
film 1 with a 2.6mm diameter aperture at the center is used to block all the excitation photons 
leaking from the fiber bundle. Covering film 2 is a transparent film used to record total escaping 







Figure 31. Scheme of simulation system of bifurcated fiber bundle system. Core is 200μm in diameter. 
NA=0.2; 37 fibers for excitation; 41 fibers for emission 
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4.2.4 In vitro experimental evaluation 
4.2.4.1 Static experiments 
Static in vitro experiments were performed to evaluate 1) accuracy of the measured optical 
properties of phantoms; 2) accuracy of the simulation system including Monte Carlo ray-tracing 
and geometric ray-tracing; and 3) the capability of the designed hardware working with the 
developed highly-scattering skin phantoms. A patch of sensor samples were immobilized on 
double-sided sticky tape attached to a glass slide and then it was covered by a skin phantom. 
Skin phantoms were placed adjacent to the last lens of part B of hardware (Figure 28) in 
experiments. The hardware system was mounted vertically in experiments. It delivered and 
focused excitation light on to a skin phantom and collected emission of sensors propagating 
through covering skin phantoms with different thickness. Power of excitation light focused on 
the skin phantom was 0.25mW and forming a spot with 2.5mm in diameter, so the average 
exposure intensity on a skin phantom was 0.051mW/mm2 that was 39times smaller than the 
Maximum Permissible Exposure of human skin (MPE=2mW/mm2)[107]. A grating-CCD 
spectrometer (USB 4000, Ocean Optics Inc.) connected with the hardware via an optical fiber 
was used to spectrally analyze luminescent emission collected. The integration time of the 
spectrometer was 25ms for every measurement in static in vitro experiment.  
 
4.2.4.2 Dynamic experiment 
Sodium alginate (low viscosity, 250 counts/s, MW 12-80 kDa), (3-glycidyloxypropyl) 
trimethoxysilane (GPTS), ammonium hydroxide, glucose oxidase (GOx, type VII from 
Aspergillus niger, 198 k units/g solid), catalase (CAT, from bovine liver, 2950 k units/g solid), 
β-D-glucose, and sodium acetate buffer were obtained from Sigma. Rhodamine isothiocyanate 
(RITC), sodium poly (styrene sulfonate) (PSS, MW ~70 kDa) and poly (allylamine 
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hydrochloride) (PAH, MW ~70 kDa) were obtained from Aldrich. Platinum(II) 
octaethylporphine (PtOEP) was purchased from Frontier Scientific. Tetrahydrofuran (THF, 
Fluka) and N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) were 
obtained from Fluka. N-hydroxysulfosuccinimide sodium salt (NHSS) was purchased from 
Toronto Research Chemicals, Inc. An alginate-silica (“algilica”) precursor was prepared by 
stirring a solution comprising 1.5 wt% aqueous alginate solution and glycidyl silane (GPTS) in a 
1:1 volumetric ratio.  Then, 2 mL of the precursor was added to 3 mL of water, and 1.25 mL of 
10 M NH4OH was added to initiate the sol-gel process, followed by the addition of 10 mL of 
water and an additional stirring time of 40 min. An electrical sensing zone particle sizer 
(Micromeritic orifice was used to obtain the size distribution and concentration of particles 
comprising the stock suspension. In dynamic in vitro experiment, a flow-chamber apparatus 
(Figure 32) was used to control environmental variables (oxygen, glucose concentrations). Part B 
of hardware system was coupled into the flow-chamber to excite a sensor patch and collect 
luminescent emission. Setup of the hardware system and mobilization of the sensor patch were 
the same as that in static experiment, except that a sensor patch mobilized on a glass slide was 
then covered by a skin phantom on the other side of glass slide (Figure 32), because swelling of 
silicone skin phantom due to inner pressure of chamber needed to be avoided in order to keep 
thickness of the phantom constant. Excitation light from a green LED (λpeak=530nm, LS-530, 
Sandhouse, Dunedin, Florida, USA) was focused on the skin phantom with thickness of 372μm. 
The power of excitation light focused on the skin phantom was much smaller than that used in 
previous static in vivo experiment to avoid intense photon bleaching of sensors. Integration time 
of the spectrometer was 3s. All of the instrumentation (pumps, oxygen electrodes, mass-flow 
controllers, and the spectrometer) was controlled by a PC using a custom LabVIEW Virtual 
Instrument (National Instruments).  The test was performed with the help of Brad Collier. 
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4.3 Results and discussions 
4.3.1 Efficiency of hardware system 
The simulated interrogation and collection efficiency of the hardware system was compared with 
that of the fiber bundle in Figure 33. The interrogation efficiency of hardware system was 200 
times higher than that of the fiber bundle without a phantom covered on a sensor patch, and it 
dropped as the phantom went thicker, and it was 37 times higher than that of the fiber bundle 
with a 1.01mm phantom. Because the escaping luminescent photons spread wider at the deeper 
implantation depth, more photons escaped from the system. The collection efficiency of the 
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system was 320 times higher without a phantom and dropped to 62 times higher than that of the 
fiber bundle when the sensor was covered with a 1.01mm phantom covering. We also tested the 
interrogation efficiency experimentally using a power meter. The designed hardware system was 
~100 times higher than that of the fiber bundle without phantom covered. The luminescent signal 
was too small for the power meter when covered with a phantom. This mainly because the 
sensors mobilized on a slide were not uniform and all the light source, filters and dichroic mirror 
in simulations were ideal but not in the experiment. There was a big photon loss up to 99.4% 
observed in experiments due to fiber connections of the spectrometer, so we could not use 
spectrometer to test the interrogation efficiency. The big photon loss needed to be overcome in 








 A diagram of the hardware design is provided as below. In Figure 34, part A is for 















































used to collimate the excitation light from a green LED (λpeak=530nm). The excitation filter in 
part A (560nm short pass, 3RD560SP, Omega) was used to cut the spreading tail of light source 
in the longer wavelength range. The dichroic mirror (Omega) mounted 45° was used to reflect 
excitation light into part B and to allow emission light to go through. Part B focused excitation 
light onto skin (phantom). A bi-convex lens (f=25.4mm) and a plano-convex lens (f=25.4mm) 
are used to focus the excitation light onto skin. Part C is for coupling of collected luminescent 
emission light into a spectrometer via an optical fiber (NA=0.37, D=0.4mm). An aspheric lens 
(NA=0.51, f=7.86mm, Thorlabs®) is used to couple luminescence light into the fiber. The 
emission filter in part C (3RD570LP, Omega) was used to filter out the excitation light leaking 




Figure 34. Diagram of the optical system. 
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4.3.2 Optical properties of evaluation phantom 
For the phantoms with reliable collimated transmittance (four of fourteen samples), absorption 
coefficient (μa), scattering coefficient (μs), and anisotropy factor (g) were obtained from “three-
measurement” with MR, MT, and MC as inputs in IAD calculation. For other phantoms that 
were too thick to get reliable collimated transmittance (ten of fourteen total samples), absorption 
coefficient (μa) and reduced scattering coefficient (μs’ = (1-g) × μs) were obtained through “two-
measurement” with MR and MT as inputs in IAD calculation. 
 The optical properties of skin phantoms were calculated using IAD software with the 
input of MR, MT and MC (if desired). To check the collimated transmittance (MC) was reliable or 
not, it was plotted versus thickness of samples. Figure 31 contains a plot of averaged collimated 
transmittance at six wavelengths (540, 570, 585, 620, 635, 645, and 665nm) from which it can be 
seen that the reliable collimated transmittance (solid circles in Figure 35) decreased 
exponentionally versus phantom thickness. The unreliable MC (solid triangles in Figure 35) 
would not be used as input in the three measurement method in IAD calculation. Data point “a” 
was eliminated, because R-square (0.87) was smaller than 0.95 if data point “a” was involved in 
linear regression. Data points “b – f ”  were eliminated since they were smaller than 7.5×10-5 
which had the same order of magnitude as the smallest resolution of collimated transmittance 
(2.5×10-5) determined by the maximum photon counts (40000) detected during measurement. 
Data points g - j were originally zeros and were added 1×10-6 to be plotted in log scale in Figure 
35. Intercept of the linear regression line must pass through the  value when the phantom 
thickness was zero, which was the transmittance calculated from Fresnel’s law . This can be 
roughly calculated using the refractive indices of glass (n = 1.5) and air (n = 1), when the 
multiple internal reflectances were neglected. When sample thickness was 0, the calculated MC = 
0.964 = 0.85, which was close to the measured values (0.85).  Unreliable data points may be 
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 For the phantoms with reliable collimated transmittance (four of fourteen samples), 
absorption coefficient (μa), scattering coefficient (μs), and anisotropy factor (g) were obtained 
from “three-measurement” with MR, MT, and MC as inputs in IAD calculation. For other 
phantoms that were too thick to get reliable collimated transmittance (ten of fourteen total 
samples), absorption coefficient (μa) and reduced scattering coefficient (μs’ = (1-g) × μs) were 
obtained through “two-measurement” with MR and MT as inputs in IAD calculation. 
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error bars are one standard deviation. In Figure 36, solid diamonds are measured μa of phantoms. 
The solid line and dashed lines are extracted from Jacques’ work [140-142]. Solid line at the top 
is the μa of darkly pigmented skin (melanosome 30.5%); the dashed line in the middle is the μa of 
the moderately pigmented skin (melanosome 13.8%); dashed line at the bottom is the μa of light 
skin (melanosome 3.8%); open circles are extracted from  Bashkatove et al’s work [139]; open 
triangles are extracted from Prahl’s thesis [143]; open diamonds are extracted from Chan et al’s 
paper [144] ; open squares are the volumetric average μa of skin based on the μa of stratum 
corneum, epidermis and dermis summarized in Van Gemert’s paper [102]. The phantom data 
agreed well with the μa (solid line in Fig. 2) of darkly pigmented adult’s skin with a typical 
volume fraction of oxygenated-blood 0.2%  in dermis, and they also agreed well with μa (open 
squares) summarized in Van Gemert’s paper , and at longer wavelength range, μa of phantoms 
agreed with Chan et al’s data (open diamonds) . Other than these data, they are higher than other 
published data. Jacques’ data (solid line and dashed lines) were the volumetrically averaged 
value of μa of epidermis (100μm) and μa of dermis (1900μm) [145]. In Jacques’ work, μa of 
epidermis was the sum of μa of skin baseline and μa of melanosome. Absorption (μa) of skin 
baseline was based on the measurement of bloodless rat skin using integrating sphere from 
unpublished data of Huang and Jacques [140], and μa of melanosome was based on the various 
published studies of the threshold exposure for explosive vaporization of melanosomes by pulsed 
lasers at various wavelengths [140-142]. The fractions of melanosome used for calculation of μa 
of epidermis are 3.8%, 13.8% and 30.5% which are the average value of fraction for light skin, 
moderately pigmented skin and darkly pigmented skin [142]. Bashkatove’s Data (open circles) 
[139] were the μa of samples obtained from post-mortem examinations. Prahl’s [143] data (open 
triangles) was obtained from bloodless human dermis. Chan’s data (open diamonds) in  were the 









 The reduced scattering coefficients (μs’) of phantoms were compared with those in 
publications in Figure 37. Solid diamonds are μs’ of phantoms; open squares are the volumetric 
average μs’ of epidermis and dermis extracted from Wan et al [146] and Anderson’s [147] work 
respectively; dashed line is extracted from Jacque’s work [140, 148]; open triangles were 
extracted from Prahl’s thesis [143]; open circles are extracted from Bashkatove et al’s paper 
[139]; open diamonds were extracted from Chan’s paper [144]; crosses were predicted μs’ based 
on Mie scattering. The μs’ of phantoms (solid diamonds) were obtained from fourteen samples 
using “two-measurement” IAD calculations. The phantom data did not have an obvious 
decreasing trend versus wavelength, which was similar as the predicted values (crosses in Figure 
33) by Mie scattering calculations. The reduced scattering coefficients of phantoms were higher 
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than most published data except the averaged of Wan [146]and Anderson’s [147] data at shorter 
wavelength, but μs’ of phantoms agreed well at longer wavelength with them. 
 The published μs’ of skin were averaged according to the volume fraction of epidermis 
(100μm) and dermis (1900μm) [145]. Jacques’ data (dashed line) was the sum of μs’ of Mie 
scattering from collagen fibers and μs’ of Rayleigh scattering from small-scale structures [140, 
148]. Predicted values (crosses) were results of Mie scattering caclulation based on the uncured 










 The measured scattering coefficients (μs) of phantoms were compared with published 
scattering coefficients in Figure 38. The measured scattering coefficients of phantoms were 
obtained from calculation of reduced scattering and anisotropy factor obtained from four of 
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fourteen samples calculated with “three-measurement” method of IAD. Scattering coefficients 
from publication varied a lot, as well, while the phantom data were close to one of maximum 
value of published data. Scattering coefficients of Jacques’ data (dashed lines) were calculated 
from the reduced scattering coefficients with the g varied from 0.7 to 0.95 [140, 148, 149]. The 




Figure 38. Scattering coefficient (μs) 
 
 
 Measured anisotropy factors (g) of the phantoms (solid diamonds) given in Figure 39 
were also obtained from four of fourteen samples with “three-measurement” method of IAD. 
The g were within the range 0.7 to 0.95 which is the range of anisotropy factors of skin  in [140, 
149]. The anisotropy factors of phantoms were close to upper boundary of published values, as 
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well as the predicted values (crosses). However, for the photon diffusion in biological tissue 
which involves many scattering events, the details of scattering coefficient (μs) and anisotropy 
factor (g) become less important than reduced scattering coefficient (μs’) [140]. As long as the 
anisotropy factor and scattering coefficients of phantoms are in between the maximum and 
minimum published values, and they should be sufficient for our purpose. 
 The optical properties of skin phantoms were aimed to match the maximum published 
values to our knowledge to present an evaluation medium of highest attenuation. The absorption 
coefficient of phantoms matched those of darkly pigmented skin published so far. The reduced 
scattering coefficients also matched the highest published values to our knowledge. As system 
evaluation mediums, the skin phantoms can enable the system testing and optimization without 




Figure 39. Anisotropy factors (g). 
 
 89 
4.3.3 Comparison of static experiment and simulations 
In experiments, the emission generated from a patch of sensor samples and transporting through 
a skin phantom was collected by the optical system and analyzed by the spectrometer. In 
simulations, six wavelengths were simulated for the optical system and skin phantom models 
with various thicknesses. The attenuation ratios at three typical wavelengths (585, 620 and 
645nm) were calculated for comparison. In Figure 40, solid triangles are results of simulations 
that were applied parameters resulting in maximum effective attenuation coefficients, which 
predict the lower boundary of attenuation ratios. The solid squares are results to predict the upper 
boundary of attenuation ratios. In Figure 40, all the experimental data (open diamonds) fall in 
between the predicted upper and lower boundary of attenuation ratios, which proved the 
accuracy of measured optical properties of phantom. The slopes of experimental data in Fig. 36 
were 10.52, 10.01, and 10.08 for 585, 620 and 645nm, respectively. The average effective 
attenuation coefficients (μeff2 = 3μa×( μa+ μs’)) of phantoms are 5.17, 3.83, 3.40, and 3.37 (1/mm) 
for 540, 585, 620 and 645nm, respectively. The total attenuation of luminescence should be 
associated with the sum of μeff of excitation (540nm) and emission (585, 620, 640nm) 
wavelengths. Because 540nm was the only excitation wavelength simulated, the sum of μeff of 
excitation wavelength and emission wavelengths were 9.0, 8.57, 8.55 (1/mm) for 585, 620 and 
645nm respectively. The differences of the slopes in Fig. 36 and the sum of μeff of excitation and 
emission were around 15%, this may be attributed to the differences of interrogation efficiency 












 In previous work [150], the measurability of luminescent signal was predicted and the 
luminescent signals generated from implants were concluded to be detectable at all depths 
(0.5~1.7mm) within the dermis using detectors such as avalanche photodiodes or photomultiplier 
tubes. The intensity of excitation light focused on skin phantoms in static in vitro experiment 
was 0.051mW/mm2 that was 40 times smaller than MPE of human skin. In experiments, the 
luminescent signal through phantoms up to 1010μm thick was detectable using a grating CCD 
spectrometer. The detectability was determined according to the detectable signal that was on the 
same order of magnitude of dark signal. Therefore, any signal smaller than that should be 
unreliable. If the incident excitation light was the MPE of human skin, the detectable thickness 
could be around 1357μm according the equations in Figure 19. The measurability also depends 
on the types of detectors, if a more sensitive detector would be used, the detectable thickness 
could be greater. 
 
4.3.4 Dynamic experiment 
 Figure 41 (a) and (b) are the result obtained from in dynamic flow-chamber in vitro test. 
Luminescent emission through a 372μm skin phantom was collected by the hardware. The 
percentage changes of peak ratios (PtOEP 645nm /RITC 585nm) versus different glucose 
concentrations. The baseline is the peak ratio at zero glucose concentration. The analytical range 
is defined as the concentration range of glucose which can be statistically differentiated. The 
lower limit of the analytical range is defined as detection limit, while the upper limit is the 
analyte concentration observed when the response profile deviates 10% from linearity.[29] In 
Figure 41, it was observed that upper limit of the analytical range was smaller than 100mgL. The 
analytical range of 2~120mg/dL was reported [29, 30] previously. This might be attributed to 
several factors: 1) the filters in the optical system were not ideal so they could not filter out of 
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the back scattered excitation light which introduce more noise; 2) there were some interference 
between the reference emission and sensing emission. The scattering coefficient of the phantom 
used in this experiment was ~80mm-1 which is much higher than that of animal skin. Figure 37 
indicates that the sensor response through a 337μm skin phantom to different glucose 
concentration was measurable, though the analytical range was affected. Thus, it was anticipated 
that there should be no significant obstacle to observe the sensor response to variation of glucose 







Figure 41. (a) in vitro data of peak ratios (645nm/585nm), (b)  % changes of peak ratios (645nm/585nm) 









4.4 Conclusions  
An optical system of high efficiency was designed to interrogate dermally-implanted 
microparticle sensors. The evaluation medium is the developed silicone-based skin phantoms 
which match the maximum value of the published optical properties of human skin. The 
phantoms have advantages of stability and feasibility to produce multi-layered structures and can 
be used to facilitate the evaluation and optimization of the hardware system. Experimental 
validations showed a good agreement with results of simulations, proving the accuracy of 
measured optical properties of developed skin phantom, and the accuracy of the simulation 
system including Monte Carlo ray-tracing and geometric ray-tracing. Further development and 
many more experiments are required to establish whether the proposed implantable sensor 
technology can yield accurate blood glucose predictions, and how long the implants can operate 
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in situ.  However, these evaluation of the hardware system with skin phantoms indicate that there 
should be no obstacles for the optical hardware to meet expectations for in vivo analysis of 
implants. The phantoms and optical system will be used for extensive in vitro sensor validation 
prior to use in animal experiments, and more animal experiments will be carried out in the 
future, as well. We also need to point out that photon loss at the connections of hardware needs 






5. OPTIMIZATION OF THE OPTICAL SYSTEM 
 
5.1 Significance and background 
5.1.1 The problem of photon loss with commercial spectrometer 
During experimental evaluations performed in Section 4, it was noticed that the system 
efficiency was compromised due to the photon losses between the fiber connections and the 
entrance aperture of the CCD spectrometer. The photon loss was found to be 99.97% with a 
0.7mm thick phantom when measured with a power meter. This matched predictions from 
simulations wherein the photon loss between the fiber and entrance aperture of a spectrometer 
was greater than 99.9% with covering phantom models, and it went up as thickness of phantoms 
increased. Even without a phantom covering on the model of a sensor patch, there was still 
99.85% of photon loss at the entrance of the spectrometer. Photon loss of the system in 
simulations was around 99.93%, 99.96% and 99.97% with 0.268, 0.576 and 1.01mm thick 
phantom models, respectively. The problem of photon loss is an inevitable trade-off of the 
spectrometer, and highlights the need for a custom solution to improve optical efficiency for the 
weak signals expected from implanted sensors. 
 
5.1.2 The optics of spectrometers [150] 
5.1.2.1 Basic structure 
There are many configurations of an optical spectrometer, but the basic structure of an optical 
spectrometer consists illumination, collimation, dispersing, focusing and detection system 
(Figure 42). Illumination is the object that a spectroscopic system is applied to study. It can be a 
certain light source, or luminescence from a sample excited by a light source. The collimation 
system is composed of an entrance slit and collimating optics. Light that enters the entrance slit 
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is collimated by collimating optics before getting dispersed. The size of the entrance slit can 
affect the system resolution and throughput. The dispersing system can be a grating or a prism, 
which depends on the applications. The dispersing system also controls the spectral resolution. 
The focusing system focuses the dispersed light onto the image plane. The detection system 










 The dispersing system is the major part of a spectrometer. The most common dispersing 
components used in spectrometers are prisms and diffraction gratings. The advantage of a 
dispersing prism (Figure 43) is that it has nearly 100% transmission efficiency. However, the 
disperse angle is small compared with a diffraction grating. Either enlarging the work space or 
adding multiple mirrors may work when using prisms, but it is hard to build a compact setup. 
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 A diffraction grating (Figure 44) is a collection of reflecting (or transmitting) elements 
separated by a distance comparable to the wavelength of light under study[152]. A reflection 
diffraction grating consists of a grating superimposed on a reflective surface, whereas a 
transmission diffraction grating consists of a grating superimposed on a transparent surface.[153] 
The most fundamental grating equation that states the relationship between the groove density of 
a grating and the angles of the incident and diffracted beams is given as: 
                  (26)  
 
In the grating equation, N(1/mm) is the groove density of a grating, m is the diffraction order, α 
and β are the incident and diffracted angles, and λ (nm) is the incident wavelength.  
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5.1.2.2 Dispersion of a grating 
The angular dispersion is the angular spread dβ of a spectrum of order m between the wavelength 





      
    
 (27)  
 The ratio of dβ and dλ is angular dispersion. As the groove density (N) increases, the 
angular dispersion increases, which means that the angular separation between wavelengths 
increases for a given order m as the groove density increases. 
 The linear dispersion of a grating system is the product of the angular dispersion and the 
effective focal length (f) of the grating system. It defines the extent to which a spectral interval is 




     
    
  (28)  
where, f is the effective exit focal length in mm. 
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 The linear dispersion is the ratio of dx to dλ. Thus, according to the linear dispersion 
equation above, we can see that a longer effective focal length (f) can yield a bigger linear 
dispersion, which means that a spectral interval can spread out wider across the focal plane. The 
reciprocal linear dispersion (dλ/dx) is called the “plate factor” (pf). The pf is a measure of the 
change in wavelength (nm) responding to a change in position along the spectrum. A longer 
focal length can result in a smaller plate factor, which results in a smaller change in wavelength 
responding to a change in location, so longer focal length can result in a better wavelength 
resolution. 
 
5.1.2.3 Resolving power, spectral resolution and band-pass [152] 




 (29)  
where, dλ is the limit of resolution, the difference in wavelength between two lines of equal 
intensity that can be distinguished. The theoretical resolving power of a planar diffraction grating 
is given as: 
R=mN’ (30)  
where m is the diffraction order, and N’ is the total number of grooves illuminated on the surface 
of a grating. The grating equation can be used to replace m as below: 
  
    (         )
  
 (31)  




thus ,     
  (         )
 
 
because |         |    
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The maximum attainable resolving power is: 
     
      
 
 (32)  
 The degree to which the theoretical resolving power is attained depends not only on the 
incident and diffraction angles, but also on the quality of the grating surface, the uniformity of 
the groove spacing, the quality of the associated optics, the width of the slits and detector 
elements, and aberrations. Any departure of the diffracted wavefront greater than λ/10 will result 
in a loss of resolving power due to aberrations at the image plane. 
 Though the resolving power can be considered as a characteristic of the grating, it is 
important to note that the ability to resolve two wavelengths depends not only on the grating but 
also on the dimensions and locations of the entrance and exit slits, the aberrations in the images, 
and the magnification of the images. The minimum wavelength difference between two 
wavelengths that can be resolved unambiguously can be determined by convolving the image of 
the entrance aperture (at the image plane) with the exit aperture (or detector element). This 
ability of a grating system to resolve wavelengths is arguably more relevant than resolving 
power, since it takes into account the image effects of the instrument system. Resolving power is 
a dimensionless quantity, and resolution has spectral units. 
 The band-pass and resolution are both used as a measure of the instrument’s ability to 
separate adjacent spectral lines. The band-pass (BP) of an instrument is the spectral interval that 
can be isolated. It depends on the following factors: the width of the grating, system aberrations, 
spatial resolution of the detector, and entrance and exit slit widths. Spectrometers are not perfect: 
they produce an apparent spectral broadening of the purely monochromatic wavelength. The line 
profile has finite width and is known as the instrument line profile (instrumental bandpass). An 
estimation for bandpass is the product of the exit slit width w’ and the reciprocal linear 
dispersion. 
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        (33)  
 An instrument with a smaller bandpass can resolve wavelengths that are closer together 
than an instrument with a larger bandpass. The bandpass can be reduced by decreasing the width 
of the slit, but usually at the expense of decreasing light power as well. 
 Assuming monochromatic light, the bandpass is defined as the full width at half maximum 
(FWHM) of the trace. Because any spectral structure is the sum of infinite number of single 
monochromatic lines at different wavelengths, the relationship between the instrumental line 
profile, the real spectrum and the recorded spectrum is given by: 
 ( )   ( )   ( ) (34)  
The recorded function F(λ) is the convolution of the real spectrum B(λ) and the instrumental line 
profile P(λ). The shape of the instrumental line profile is a function of various parameters: 1) the 
width of the entrance slit; 2) the width of the exit slit or of one pixel; 3) aberrations; 4) quality of 
the system’s components and alignment; 5) diffraction phenomena. Each of these factors can be 
characterized by a special function Pi(λ), thus the overall instrumental line profile P(λ) is related 
to the convolution of the individual terms: 
P(λ)=P1(λ)*P2(λ)*…*Pi(λ) (35)  
Thus, a spectrometer with a smaller-width slit, smaller-pixel detector and less aberration can 
have a narrower instrumental line profile, which results in a better spectral resolving ability. In 
summary, according to the definitions of linear dispersion, resolving power, and bandpass, the 
spectral resolving ability of a spectrometer is mainly dependent on these factors: 1) groove 
density of the grating (if a grating is used); 2) the effective focal length of the spectrometer; 3) 




5.1.2.4 Throughput and etendue [150] 
Geometric etendue, (G), characterizes the ability of an optical system to accept light. It is a 
function of the area (S) of the emitting source and the solid angle (Q), into which it propagates. 
Etendue is a limiting function of system throughput. 
  ∬     (36)  
In a spectroscopic system, the etendue is estimated by: 
        (37)  
where, Ses is the area of the entrance slit. 
 Thus, the throughput of the system basically depends on 1) size of entrance aperture and 
slit; 2) numerical aperture. Thus, there is an inevitable trade-off between spectral resolution and 
throughput of a spectrometer system. As noted above, spectral resolution can be increased by 
decreasing the entrance slit and numerical aperture that can result in smaller aberrations at the 
expense of sacrificing the light power. 
 
5.1.2.5 The optical invariant 
The optical invariant (Lagrange invariant) is a constant for an optical system. In Figure 45, the 
optical invariant throughout the entire system is defined as below: 
               (38)  
where, h and h’ are the heights of object (S) and image (S’), u and u’ are the ray slopes of object 
and image, and n and n’ are the refractive index of object space and image space, respectively. 
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Thus, the equation above can be rearranged to give a generalized expression for the 







    
 (39)  
 
As the image magnification increases the angular magnification decreases. Therefore the 
problem of photon loss is caused by the “illumination” being bigger than the entrance 
slit/aperture of the collimation system. In section 4, the optical system was designed to deliver 
excitation light and collect luminescence emission generated from implantable sensors. 
Therefore, this system formed an image of the luminescence spot onto the entrance slit/aperture 
of the spectrometer. The luminescence spot was generated from the implanted sensor patch and 
was blurred a lot while travsersing the skin or phantoms. The image size of the luminescence 
spot is determined by the transverse (lateral) magnification (m), and the output numerical 
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aperture (NAout) is determined by angular magnification, which is the reciprocal of the transverse 
magnification (1/m).  Therefore, the image size decreases as the output numerical aperture 
increases. However, typically the size and numerical aperture of entrance aperture in a 
commercial spectrometer is small in order to increase resolution and decrease the effect of 
aberrations. Because the NAin was already designed to be big enough to capture as much 
luminescence light as possible, a small image size and small NAout cannot be obtained 
simultaneously; thus, it is important to recognize that the photon loss at the connection of the 
optical system and a commercial spectrometer is inevitable. 
 
5.1.3 Rationale of system optimization 
The entrance aperture and slit of most current commercial spectrometers are usually small 
(~hundreds microns) due to the aim of obtaining high spectral resolution and compact structure. 
The design aiming for high resolution results in decreased signal intensity due to the trade-off 
between spectral resolution and input energy. The optical system (designed in section 4) for 
delivery of excitation and collection of emissions can be considered as the illumination part of a 
spectrometer system as shown in Figure 38. Moreover, for luminescence measurements, only 
specific, relatively broad bands of the spectrum are of interest. For example (Figure 46), our 
ratiometric sensors exhibit emission peaks at 585nm (FWHM≈50nm) and 645nm 
(FWHM≈30nm). Furthermore, luminescent signals collected from tissue or implants will be 
strongly attenuated by tissue scattering and absorption (~10-4); therefore, signal power should 
take priority over spectral resolution for luminescence. The minimum acceptable resolution is to 
resolve these two emission peaks. 
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Figure 46. Excitation and emission spectra of sensor particles. For the absorption spectrum shown, 
[PtOEP] is 10nM. Environmental [glucose] is 250mg/dL. Blue circles and numbers indicate the 




 For this application, a more appropriate high-efficiency hardware system that integrates 
delivery of excitation, collection of luminescence, and measurement of luminescent spectra is 
needed. It should have high throughput and obtain spectral resolution good enough for our 
luminescence-based implantable sensors. The aim of this chapter is to investigate system 
optimization methods to overcome photon loss at the fiber coupling of the designed optical 
system and a commercial spectrometer.  
 
5.2 Two-detector system 
To overcome the photon loss between the fiber coupling of the designed system and a 
commercial spectrometer, two optimization approaches were investigated. The first approach 
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was to replace the commercial spectrometer with a two-detector system. The second approach 
was to replace the commercial spectrometer with a customized spectrometer system, which will 
be discussed in section 5.3. The design requirements of the system optimization were 1) 
minimum spectral resolution of 60nm to resolve the two emission peaks at 585nm and 645nm; 2) 
reduce photon loss at the fiber coupling with the commercial spectrometer. The pros and cons of 
these two approaches will be discussed in section 5.3.4. 
 
5.2.1 Method of two-detector system 
5.2.1.1 System design 
Because the luminescence generated from our sensors was broad-banded, and only the reference 
peak and oxygen sensing peak were used as key information, the spectral information at other 
wavelength ranges was not critical to the measurement of the sensor response, as long as the two 
emission peaks could be extracted. Therefore, a two-detector system with a long-pass dichroic 
mirror was designed to extract the desired spectral information. The dichroic mirror separated 
the two luminescence emission peaks, and two band-pass filters were used to isolate the two 
emission peaks of the reference dye (585nm) and the sensing dye (645nm). Emission photons 
were focused onto photodiode detectors (Figure 47), which also measure the power of the 
extracted emissions. Figure 47 is a simplified representation of this design. 
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Figure 47. Scheme of two-detector system to extract two emission peaks at 585 and 645nm. 
 
 
 In section 3, the peak ratios of intensities of the emission at 645nm to 585nm and the 
percentage change in the peak ratios were calculated. The calculations below prove that the 
percentage change of the intensity of broadband spectra is still proportional to the concentration 
of glucose. Because the intensity of light source or the environment may change over time, time 
(t) is used in calculation. Here, Iref(585, t) is the emission intensity of the reference dye at a single 
wavelength (585nm), and ∑Iref (λ, t)is the sum of emission intensities of reference dye within a 
broadband spectrum (λ was the wavelength, and t was the time), and since the reference emission 
was stable in various glucose concentrations, Iref(585, t) and ∑Iref(λ, t) were irrelevant to glucose 
concentrations (C). Isen(645, C, t) is the emission intensity of the sensing dye at a single 
wavelength (645nm), and ∑Isen(λ, C, t) is the sum of the emission intensities of the sensing dye 
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in a broadband. Because theoretically [29, 30], the Isen(λ, C, t)is linearly correlated to glucose 
concentration (C) in linear operation range,  there is a linear relationship:  
    (     )     (   )   (   ) (40)  
Therefore, the percentage change of ratios of emission intensity at 645nm to that at 585nm 
should be linearly correlated to glucose concentration, which is shown in the following 
equations, where t0 is the time when environmental glucose concentration is zero. 
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which still has a linear relationship with glucose concentration (C). 
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In the equations above, [a, b] and [c, d] are the wavelength ranges of the band-pass filters 
extracting the spectra of emission from the sensing dye and the reference dye, respectively. Isen(λ, 
0, t0) is the baseline when the glucose concentration is zero. From the equations above, we can 
see that the percentage changes maintain a linear relationship with the glucose concentrations 
when the broad-banded spectra were extracted.  
 According to Equation 43, the linearity (R-squares) were not affected by the wavelength 
ranges theoretically, since the percentage change is theoretically linearly related glucose 
concentration. The sensitivities (slope of percentage change versus glucose concentrations) were 
relevant to the wavelength range ([a,b]) according to the following equations. 
      
∑  (   )     
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 (44)  
Where, t0 is the time when glucose concentration is zero. 
 
Regardless the signal drifting with time,  thus: 
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After averaging the data over time: 
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5.2.1.2 Selection of filters 
To determine suitable wavelength ranges of the band-pass filters ([a, b] and [c, d] as shown in 
Figure 48), calculations were performed with MATLAB. Because the sensitivity (slope) and 
linearity (R-square) are the factors relevant to the performance of sensors, the goal of 
optimization is to maximize the sensitivity (slope) and linearity within the wavelength ranges 
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that still maintain enough intensity for experimental measurement. According to Equation 43, the 
percentage change is theoretically linearly related to glucose concentration, thus linearity is not 
relevant to wavelength range. In Figure 48, the lower boundary of wavelength range of sensing 
dye is around 610nm, thus the upper boundary (d) of the wavelength range ([c, d]) of reference 
dye  need to be smaller than 610nm. To avoid the overlap of wavelength range of excitation light 
source, the lower boundary (c) of the wavelength range need to be bigger than 550nm, if a band-
pass green excitation filter with FWHM of 10nm at 530nm is used. In order to maximize the 
emission intensity over ([c, d]) and minimize the interference from light source and emission of 
sensing dye, the wavelength range ([c, d]) was determined to be 550 – 610nm, thus the FWHM 








The k(λ, t) and m(λ, t) were calculated using MATLAB and are shown in Figure 49 and 50,  





Figure 49.  k(λ, t) over λ 
 
 




 Figure 51 is a plot of the calculated slopes of percentage changes versus glucose 
concentrations, which is the ratio of ∑k(λ, t) to ∑m(λ, t) over  λ   [a, b]. In Figure 51, the slopes 
(sensitivities of the response to glucose) increase until “a” reaches 650nm.  However, the sum of 
the emission intensities ∑Isen(λ, C, t) (Figure 52) decreases as “a” increases (Figure 48). 
Therefore, “a” needs to be a wavelength that balances the sensitivity and the intensity. The lower 
boundary of the emission of sensing dye is 610nm, thus lower boundary (a) can be around 













5.2.1.3 Selection of detectors 
The criteria of the selection detectors of the two-detector system are 1) sensitive enough to 
respond the light on the order of 10nW (Given the attainable excitation light input is 1mW, and 
the output is on the order of 10nW after going through a ~1mm thick skin phantom estimated 
from the equation in Figure 19); 2) proper wavelength range (500-700nm); 3) active area big 
enough (bigger than the size of the focusing spot that is 2mm in diameter); 4) compact; 5) low-
cost; 6) easy to mount.  
 For the required sensitivity, wavelength range and cost, silicon photodiodes are selected, 
because GaP photodiodes cannot attain the required sensitivity, Ge photodiodes are not for the 
visible wavelength range but for NIR wavelength range, and InGaAs photodiodes are costly 
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compared with silicon devices. As the active area needs to be bigger than 2mm in diameter, the 
photodiode DET110 (Thorlab) was chosen, because it has active area as 13mm2 
(3.6mm×3.6mm) , which matches the focusing spot size. Moreover, this photodiode is already 
mounted on a 1-inch optical coupler, which provides easy mounting of 1-inch optics and lens 
tubes. Below is the specification (Table 6 and Figure 53) of this photodiode.  
 
 










5.2.1.4 In vitro experimental evaluation of the two-detector system 
After selection of the components of filters, dichroic mirror, and the detectors, the prototype of 
the two-detector system was constructed. The experimental evaluation of the system was then 
performed both without a phantom, as well as with three phantoms of different thicknesses: 0.44, 
0.65 and 2.3mm. Each measurement was repeated 10 times to calculate the signal to noise ratio 
(SNR). The LED light source (LS-30, Sandhouse, Dunedin, Florida, λpeak=530nm) was turned on 
for 20min before starting any measurement. The sensor patch was attached onto a glass slide 
with double-sided sticky tape, and then was covered by the phantoms.  
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5.2.2 Results of the system design 
Figure 54 is a diagram of the final two-detector system. A long-pass dichroic mirror (at 610nm) 
split the luminescence emission at 610nm, and two band pass filters (580±20nm and 645±20nm) 
were used to extract two emission peaks of reference dye (585nm) and indicating dye (645nm). 











5.2.3 Results of experimental evaluation of the two detector system 
The two-detector system was constructed as shown in Figure 55. The 570nm long pass dichroic 
mirror is from Omega, and the 610nm long pass dichroic mirror is from Chroma Technology 
Corp. The two band pass filters (Chroma Technology Corp) are 580±20nm and 645±20nm. The 
two photodiode detectors (DET110, Thorlabs) have spectral response range from 350 to 
1100nm, and active area of 13mm2, and linearity limit of 1mW. A highly-scattering skin 
phantom was used to cover a sensor patch mobilized on a glass slide. Ten measurements were 
made for each phantom. In Figure 56, emission peak ratios were the ratios of two current signals 
from detectors. As shown, SNR decreased from 450 to 81 with phantom thickness increasing 
from 0.44mm to 2.3mm. However, 2.3mm is thicker than average dermis [62], thus for sensors 
implanted in dermis, these results indicate that this system will be high SNR for in vivo 
measurement. The detectable thickness of phantom using fiber bundle and the commercial 
spectrometer we used before were around 0.5~1mm depending on the concentration of the 
sensors, thus the detectable thickness using the two-detector system was 1.3 thicker than that of 
fiber bundle. The two-detector system is straightforward to design and construct; however, a 
given conformation is only useful for a typical emission pair (585nm and 645nm). Filters and 
dichroic mirrors must be specified for each type of sensor, so if the emission peaks are changed 
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5.3 Customized spectrometer 
The approach of replacing the commercial spectrometer with a customized spectrometer was 
studied as an alternative to the two-detector system. The pros and cons of these two approaches 
would be discussed later.  
 
5.3.1 Method of system design 
The key to customizing the spectrometer was to find a proper entrance aperture of the 
spectrometer system that allowed as much light input as possible into spectroscopic system while 
maintaining sufficient spectral resolution for our luminescent sensors (minimal: 60nm). As long 
as the system can resolve the emission peaks of the reference and sensing dyes respectively, the 
spectral resolution is good enough. Therefore, theoretical analysis was performed to understand 
the key factors and the design of a suitable system. Following the standard spectrometer design, 
Figure 57 shows the scheme of the system integrating the functions of excitation delivery, 






Figure 57. Scheme of optimized system integrating delivery of excitation light, collection of luminescent 
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 Part I is the optical system to deliver excitation and collect emission light designed in 
section 4. Part II is the layout of the customized spectrometer. The detected spectral intensity 
was recorded on the detector film (in simulations) in Figure 57. The image size could be 
controlled by aperture size, which also controlled the throughput.  While aiming to achieve the 
minimal spectral resolution of 60nm, the aperture size, collection lenses and detector size would 
be optimized to optimize the system throughput, and the lenses also would be optimized to 
reduce system aberrations in order to optimize the system bandpass. 
 Figure 57 shows that the luminescence light escaping from skin (phantom) was collected 
by Part I, and it was imaged onto the entrance aperture plane on Part II. Also in Part II, the 
luminescence light was collimated, dispersed and finally focused onto the detector plane. 
Luminescence light that originated from the input focal plane of the optical system went through 
collimation, focusing, and again, collimation, and focusing. In reviewing this optical layout, a 
new possibility was conceived: it should be possible to relocate the aperture/slit from Part II to a 
place as depicted in Figure 58 next to the sensor/tissue. In this case, the two additional 
focusing/collimating lenses are not needed. To investigate the effect of the position of the 










 The simulations for comparison these two designs (Figure 57 and Figure 58) were run 
with OptiCAD. The Simulation-I (Figure 59) was for the design depicted in Figure 57, and 
simulation-II was for the design depicted in Figure 58. In both groups of simulations, the power 
of the input excitation light was normalized to 1. 
 Simulation-I:  the luminescence light was passing through slit 1 (Figure 59), and slit 1 
was positioned on the focal plane of the focusing part in the middle of Figure 59. The 
luminescence was focused onto slit 1, was collimated, was dispersed by the grating, and finally 
was focused onto the detector. The lenses for “collecting”, “focusing”, and “collimating” 
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skin model 















photons collected by the 
optical system  
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configuration, because this configuration has minimal spherical aberrations and the highest 
throughput. A focusing mirror was chosen instead of lenses, because it introduces zero chromatic 
aberrations.  
 Simulation-II: the slit used to define the entrance aperture of the system, was positioned 
right in front of the skin/phantom as slit 2 in Figure 59. The grating, focusing mirror and detector 
were also moved towards the dichroic mirror.  
 In both groups of simulations, the widths of slits considered were 0.6, 1, 1.4, 2mm. 
Three phantom models with different thicknesses (268, 576, 1010µm) were used in simulations 
to simulate the capability of these systems when a phantom was placed on the sensors. The 
photon capture films depicted in Figure 59 were used to collect collimated luminescence in both 
simulation-I and II, and the photon distributions on these two films were analyzed to compare 
these two designs. The simulations were performed both without phantom models and with the 





















5.3.1.1 Selection of dispersing components 
After the optimization of the structure of the system, the specific components such as grating and 
detectors need to be determined. Although diffraction gratings do not provide a transmission as 
high as dispersion prisms, the dispersive angle is bigger than that of most prisms, thus it can 
enable a more compact setup. Moreover, the absolute efficiency of a diffractive grating can be 
more than 60% which is acceptable in practice. Among the diffraction gratings, there are four 
common types, and these are reflective ruled gratings, holographic gratings, echelle gratings and 








orders. They are generally used for high resolution spectroscopy. Because high resolution is not 
necessary for this system, it is not necessary to choose a more expensive Echelle grating. 
Transmission grating cannot enable a compact system without adding extra mirrors, which may 
make the system more bulky. Holographic gratings do not suffer from periodic errors, thus 
ghosted images are nonexistent. They are suitable in applications such as Raman spectroscopy, 
where the signal to noise ratio is an essential concern. Reflective ruled grating typically can 
achieve higher efficiency than holographic gratings due to their blaze angles [154]. Taking all 
pros and cons into consideration, the reflective ruled gratings was chosen, because it is more 
efficient than holographic gratings, less expensive than Echelle and holographic gratings, and it 
can allow a more compact system build.  
 The luminescence emission of our sensors is in the range of 550~800nm. Among 
commercially available reflective ruled gratings, there is one blazed wavelength 750nm within 
this range. Figure 60(a) and (b) contain the plots of the absolute efficiency of two gratings blazed 
at 750nm and with 600 and 1200 grooves/mm obtained from www.thorlabs.com. The 600-
groove grating has blaze angle of 13º and 1200-groove grating has a 26.44º blaze angle. The 
gratings yield an improvement in performance as the angle of incidence tends toward the blaze 
angle, since the efficiency curve tends towards the efficiency of Littrow configuration. However, 
in practice we cannot usually permit this configuration since the diffracted field will be in the 
vicinity of the incident field. [155] Thus, in order to have the difference between the angle of 
incident beam and the blazed angle as small as possible, a grating of a larger blazed angle 
(26.44º) is a superior option. Considering the size of the incident beam, a 30x30mm square 














5.3.1.2 Selection of detector arrays 
The detector array of a spectrometer is, besides the grating, the main component in the system. 
There are three types of detector arrays used in spectrometers: CCD, photodiode and CMOS 
arrays. The main parameters taken into considering are as below. [157] 
1) Pixel number – the number of pixels arranged in the line 
2) Pixel dimensions – the pixel width and height 
3) Pixel pitch - the distance between the center of two pixels  
4) Sensitivity (v/lx*s) – the wavelength dependent ratio of electrical signal output to the 
optical signal input. Sensitivity is one of the most important factors to the sensor system, because 
the detector needs to be able to detect weak signal which was attenuated by skin. Thus, the 
sensitivity of detector needs to be ~10-100v/lx*s for our sensor system (the fluorescent from 
1.7mm is estimated to be around 1E-5~7E-4 lx which depends on the concentration of particles, 
the dye concentration, quantum yield, and the intensity of the excitation light.). 
5) Wavelength range – the range of wavelengths where the detector can detect the radiation. 
Wavelength range needs to match the wavelength range of sensor emission (560~660nm). 
6) Dark signal – the output signal without illumination 
7) Saturation exposure – the illumination level at which the output signal stays constant 
with increasing the luminance. 
8) Linearity range – the luminance range where the electrical signal output is proportional 
to the impinging energy. Linearity is critical to the system as well, because the operation range 
of the sensor system depends on the response linearity of the sensors and detectors. The whole 
sensor system will be affected less if the detector has better linearity. 
9) Dynamic range – the range in which the detector is capable of accurately measuring the 
input signal. It is one of the most critical factors to the sensor system. According to the 
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simulation results showed in Figure 19, the relationship of ratios of output intensity to that of 
input and implantation depth(μm) is: y = 0.013exp(-0.0045x), thus varying the implantation 
depth within the range of 400~1700μm that is the range of dermis, the output signal from the 
depth of 400μm is 347 times more than that from the depth of 1700μm.  Since the intensity of 
the output signal depends on the implantation depths, and varies around 300, that a detector 
needs to be of a dynamic range more than 300.   
10) Pixel non-uniformity – the output signal difference of the pixels under same illumination 
conditions [%].  
 A CCD (charge-coupled device) is a device for the movement of electrical charge, 
usually from within the device to an area where the charge can be manipulated. The photoactive 
region is metal-oxide capacitors (gate electrode). During the illumination by the spectrum focal 
line, a charge (electron-hole pairs) is produced under the gate. A potential well is created by 
applying a voltage to the gate electrode. The charge is confined in the potential well associated 
with each pixel by the surrounding zones of higher potential (see detail in Figure 61). A control 
circuit drives each capacitors to transfer the charge to its neighbor (operating as a shift register). 
The last capacitor in the array dumps its charge in to a charge amplifier, which converts the 
charge into a voltage. By repeating this process, the control circuit converts all of the charges of 









 A photodiode is a type of photo-detector which is capable of converting light into an 
electric signal (either current or voltage). A photodiode is a p-n junction or PIN structure. When 
a photon of sufficient energy impingings the diode, it excites an electron, thus creating a free 
electron and a positively charged electron hole (photoelectric effect). If the photon absorption 
occurs in the junction’s depletion region, these carriers are swept from the junction by the built-
in field of the depletion region. Thus, electron holes move toward the anode, and electrons move 
toward cathode, and thus a current is produced. The total current is the sum of both the dark 
current and the light current. 1-D photodiode arrays consist of several photodiodes (pixels) 
arranged in a line. The current generated by photon absorption is integrated by an integration 
circuitry associated with this pixel. During a sampling period the sampling capacitor connects to 
the output of the integrator through an analog switch.  Figure 62 is the operation scheme of a 





Figure 62. Operation principle of photodiode arrays [157] 
 
 
 CMOS (complementary metal-oxide-semiconductor) arrays also use MOS (metal-oxide-
semiconductor) structures as pixels like the CCD arrays. The basic difference is that the charge-
to-voltage conversion takes place directly in the pixel cell, while CCD transfers the charge of 
each pixel to the next pixel until the last one, and converts the charge into voltage. The photon-
voltage conversion of CMOS arrays consists of two steps. The photon is converted to electron, 
and then the charge (electron) is converted to voltage. Figure 63 shows the scheme of a CMOS 
line array.  [157, 160] 
 
 
Figure 63. Operation principle of CMOS arrays. [157] 
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 Other detectors such as APD (Avalanche Photodiode) and PMT (Photomultiplier) are 
more expensive than the detectors discussed above. PMT requires external high voltage supply, 
which will also make the system more bulky.  
 The detectable wavelength range of silicon-based detector arrays extends from 200 to 1100 
nm, because wavelengths longer than 1100nm have lower photon energy lower than the band 
gap energy. For the application of our luminescence sensors, which emit from 550-800nm, any 
silicon-based detector arrays satisfies this wavelength range. Table 7 below is the comparison of 
feature and performance between CCD and CMOS. From Table 7, it is clear that each technique 
has pros and cons, thus the choice was mainly dependent on the types of applications. Because 
the luminescent signal we want to detect is weak and eve attenuated by skin, we want a detector 
has small noise. The luminescent signal varied a lot versus the implantation depth, thus the 
detector needs to have a good dynamic range. Because the system noise of CCD is relatively 
lower than that of CMOS, and the dynamic range of CCD is better than CMOS, the choice of 




Table 7. Feature and performance comparison [161] 
 
 
 Other than wavelength range, the sensitivity, pixel dimension, and dynamic range take 
priority affecting detector selections, because these three factors are relevant to the detection 
limitation, image size, and image power. Another factor is cost, since the whole system is aimed 
to be cost-effective. Considering all key parameters, the SONY IXL511 (specifications were 
shown in Table 8 and Figure 64) and Toshiba TCD1304AP (specifications were shown in Table 
9 and Figure 65) linear CCD-array devices were chosen as they are of good sensitivity around 
160-200v/(lx*s), acceptable dynamic range which is around 300, and pixel size is 8µm×200µm, 
and it is not expensive. Since a control PCB board for TCD1304AP was directly available, the 
Feature CCD CMOS
Signal out of pixel Electron packet Voltage
Signal out of chip Voltage (analog) Bits (digital)
Signal out of camera Bits (digital) Bits (digital)
Fill factor High Moderate
Amplifier mismatch N/A Moderate
System Noise Low Moderate
System Complexity High Low
Sensor Complexity Low High
Camera components
Sensor + multiple 
support chips + lens
Sensor + lens possible, but 
additional support chips 
common
Relative R&D cost Lower Higher
Relative system cost Depends on Application Depends on Application
Performance CCD CMOS
Responsivity Moderate Slightly better
Dynamic Range High Moderate
Uniformity High Low to Moderate
Uniform Shuttering Fast, common Poor
Uniformity High Low to Moderate
Speed Moderate to High Higher
Windowing Limited Extensive
Antiblooming High to none High
Biasing and Clocking Multiple, higher voltage Single, low-voltage
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electric circuit design was not required for TCD1304AP, thus the TCD1304AP was chosen to 
most expeditiously construct a custom spectrometer.  
 
 
Table 8. Optical and electrical characteristics of SONY IXL511 
 
 









Figure 65. Spectral response of TCD1340AP 
 
 
 The prototype system was assembled on an optical breadboard for initial evaluation. The 
control circuit was a PCB mother-board of an Ocean Optics USB4000/2000 spectrometer 
(purchased from Ebay). The excitation light power input into the system was 17.2μw, and 
 135 
filtered by a band-pass filter (530±10nm). Optical posts were used for fixing the optics in the 
prototype system. This is not as compact as desired, but the future work on further miniaturizing 
the system after all optical evaluations are completed to prove specifications are met.  
  
5.3.1.3 Experimental evaluation of the customized spectrometer system 
Experimental evaluations were performed by comparing the designed system to the bifurcated 
fiber bundle system previously used for in vitro and in vivo studies (NA=0.22, core=200µm, 37 
excitation fibers and 41 emission fibers). The skin phantoms with different thicknesses were 
used for experimental evaluation. Samples were the RITC, and the mixture of PtOEP and RITC 
solutions. A PDMS mold with a 5mm diameter hole was immobilized on a plastic petri-dish with 
a double-sided tape, and the sample solutions were poured into the mold. The phantoms were 
attached to the bottom of the petri dishes, and the excitation light was directed onto the 
phantoms. Two light sources (580±20nm and 645±20nm) were also used as calibration light 
sources. Ocean Optics USB4000 was used to collect spectra of the bifurcated fiber bundle. The 
excitation light (input=17μW) with a band-pass filter (530±10nm). Integration time varied from 
1ms to 500ms, and average of spectra was 2, and the number of boxcar smoothing was 15. 
 
5.3.2 Results of the system design 
Figures 66 - 68 contain the results of simulation-1 and simulation-II depicted in Figure 59. The 
solid lines are the results of simulation-I which simulated the slit positioned in the focal plane of 
focusing lenses. The solid circles are results of simulation-II which simulated the slit positioned 
right in front of the skin phantoms. In the legend, 0.6 (I), 1.0 (I), 1.4 (I) and 2.0 (I) represent the 
simulated results when the slit width =0.6, 1, 1.4, and 2mm in simulation (I) that was described 
previously; and 0.6 (II), 1.0 (II), 1.4 (II), 2.0 (II) represent the simulated results in simulation-II. 
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Figure 66 (a)-(d) are the intensity of luminescence photons captured on the photon capture film 
(Figure 59) versus the angles between the photons impinging on the film and the normal of the 
film. As shown in Figure 66, there are more photons with smaller incident angles as the slit is 
near the skin phantom when there is no skin model, with a 0.5mm or 0.75mm thick skin model. 
The difference between the results of slit positions with 0.75mm and 1mm skin model is not 
obvious. Figure 67 (a)-(d) are the integrated power versus the incident angles. Figure 68 (a)-(d) 
are the integrated power over the incident angles to the normal of the plane of the “transparent 
film” in simulation-I and II (Figure 52). Figure 68 (a)-(d) are the normalized integrated power 
versus incident angles. In Figure 63(a), within 2 degree, there are 57.3% (slit=0.6mm), 47.5% 
(slit=1mm), 40.8% (slit=1.4mm) and 35.4% (slit=2mm) integrated power when the slit is 
positioned in the focal plane of focusing optics which is far from the skin, in contrast, when the 
slit is positioned right in front of the skin model, the integrated power is 62.8% (slit=0.6mm), 
58.6% (slit=1mm), 54.7% (slit=1.4mm), and 54.0% (slit=2mm) integrated power.  From the 
integrated power, we can see that there is more photon power within a smaller incident angles 
and there is more photon power collected totally with slit positioned right in front of the skin 
model when the skin model is 0, 0.5 or 0.75mm. When the skin model is 1mm, there is less 
photon power within a smaller incident angles and less photon power collected totally when the 
width of the slit is 0.6 and 1mm. The normalized integrated power reveals that a greater fraction 
of total power can be captured within a small angle (<2º) when the skin model is thinner than 
0.75mm. The difference resulting from the slit position is not obvious when skin model goes to 
1mm; this may be attributed to the lower excitation power reaching the sensor. Overall, the 
simulation results indicate that the slit placed in front of the skin (phantom) increased the degree 
of collimation of luminescence photons. Moreover, the system with a slit in front of skin is 







Figure 66. Intensity distribution of photons collected on the “transparent film” in Figure 52. The inputs in 






Figure 67. Integrated power of photons collected on the “transparent film” in Figure 52. Inputs of 

















 Thus, the entrance slit was designed to be on the focal plane of the excitation light 
according to the design as shown in Figure 69. However, it is noted that this design could not 
collect as much luminescence photons as those collected by the design shown in Figure 51, in 
which the entrance slit was placed on the focal plane of focal plane of emission light. Because 
the excitation light is confined by the entrance slit, it is necessary to study the influence of the 
focal spot of excitation light on the luminescence photons escaping from the skin surface. Thus, 
simulations were performed to study the influence, and Figure 64 shows the simulated result. 
Blue diamonds are the results when the skin model thickness was 1mm, and pink circles are the 
results when the skin model thickness was 0.5mm. The luminescent emission was normalized to 
1. The skin model positions are the distance relative to a lens (LA1951, Thorlab), which was 
used in the simulations. The orange vertical line represents the where the focal plane of the lens 
is. As shown in this figure, the maximum of the escaping luminescence photons are reached 
before the focal plane of the lens. Thus, it would be better to make the optics which collect the 
excitation light from LED and deliver it to the system adjustable so as the make the spot size 
converging angle of the excitation adjustable. Since the spot size of the excitation light would be 
confined by the entrance slit, it is necessary to use a lens with a smaller focal length to make the 
incident spot size smaller. Thus a half-ball high refractive index lens with 8mm diameter was 
used as the front lens placed in front of the slit. It is able to minimize the spot size of the 






Figure 69. Normalized total escaping luminescent emission. X-axis was the skin model position relative to 




 The final design of the customized spectrometer is shown in Figure 70. The grating (NT 
46-078, Edmund Optics) was ruled at 750nm with 1200/mm groove density, and the size is 
30mm×30mm. The concave mirror (NT 43-470, Edmund Optics) is 50mm in diameter, and is of 
50mm focal length. The detector (TCD1304AP) is from Toshiba, which is the same as the one 
used in Ocean optics USB4000. The half-ball lens (NT 90-860, Edmund Optics) is 8mm in 
diameter and of high refractive index (LaSFN9). A 1mm slit was chosen for the measurement of 
the two peaks at 585nm and 645nm, and Figure 66 shows the spectral response of the system. 
With a 1mm slit, the luminescent photons collected by this customized system is simulated to be 










Figure 71. Simulated spectral response of the emissions at 585 and 645nm on the detector obtained by the 




5.3.3 Results of experimental evaluation of the customized spectrometer  
The comparisons of the hardware system and fiber bundle system testing results are presented in 
Figure 72-75. Figure 72 (a) and (b) are the spectra of the two light sources obtained by the 
hardware system and the fiber bundle system, and the integration time (IT) was kept 1ms in both 
measurements. The two light sources were obtained from the white light source (LS-1, Ocean 
Optics) filtered by two band pass filters (580±20nm and 645±20nm). In Figure 72(a), the peaks 
of the spectra obtained by the hardware system were around 9000 and 7000 photon counts. In 
Figure 68(b), the peak of 580nm was around 15000 photon counts which was higher than that 
obtained by the hardware system, but the peak of 645nm was only around 500 photon counts. 
The problem may be attributed to the poor fiber coupling or inner misalignment of the fiber 
bundles. Figure 73(a) and (b) are the spectra of the two light sources covered by a 1.24mm 
phantom, and the integration time was kept 500ms in both measurements. In Figure 73, the peaks 
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of the spectra obtained by the hardware system is 10 times higher than that obtained by the fiber 
bundle system.  Figure 74 (a) and (b) show the spectra of the two light sources covered by a 
1.74mm phantom, and the integration time was kept 500ms in both measurements. The peaks of 
the spectra obtained by the hardware is 8 times higher than that obtained by the fiber bundle. 
Figure 75 (a) and (b) show the spectra of the two light sources covered by a 2.48mm phantom. 
The peaks of the spectra obtained by the hardware is around 8 times higher. These measurements 
of the light sources aimed to compare the collection efficiency of these two systems, and the 
results agreed well with estimations. Because the numerical aperture (~0.8-0.9 depends on the 
input light source size) of the customized system is around 4 times higher than that (0.22) of the 
fiber bundle, and only around half of the fibers are for emission collection, thus the collection 
efficiency of the designed system is expected to be around 8 times higher than that of fiber 
bundle system.  For sensor interrogations, the efficiency of the delivery of excitation needs to be 
considered. Figure 76-79 show the comparisons of interrogation efficiency of these two systems. 
Figure 76 compares the conditions without phantoms. When the integration time was 8ms, the 
spectra of the emission from the samples obtained by the hardware system were ~100time higher 
than that obtained by the fiber bundle. When the phantom (thickness=0.50 mm) was attached and 
the integration time was kept 500ms, in Figure 77, the photon counts of customized spectrometer 
were still ~100 times than that of the fiber bundle. When the phantom (0.95mm) was used, in 
Figure 78 (b) there were no detectable signals observed by the fiber bundle. This increase of 
overall interrogation efficiency of the customized system is even higher than the gain in 
collection efficiency. This is mainly because the delivery efficiency of the excitation light of the 
customized system is also higher than that of fiber bundle. The excitation light delivered by the 
customized system was well focused and penetrated into the skin phantom, while the excitation 
light delivered by fiber bundle diverged and the intensity arriving at the sensors is smaller. In 
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contrast, a spectral trend can be detected with the customized spectrometer with 500ms 
integration time. The shorter wavelength range (around 580nm) was strongly attenuated, but the 
signal of longer wavelength range was detected. This was expected in simulations, because the 
skin model absorbs most emission at shorter wavelength. In simulations, the photon counts 
detected by the customized spectrometer system were 100 times higher than that detected by 
fiber bundle. The customized system should be more capable than the fiber bundle system for in 






Figure 72. Spectra of the two light sources without a phantom covered (a) obtained by the hardware 














Figure 73.  Spectra of the two light sources with a 1.24mm phantom covered (a) obtained from the 








Figure 74. Spectra of the two light sources with a 1.74mm phantom covered (a) obtained from the 









Figure 75.  Spectra of the two light sources with a 2.48mm phantom covered (a) obtained from the 







Figure 76. Spectra of the emission from RITC solutions and the mixture of RITC and PtOEP solutions, 
which was not covered by a phantom (a) obtained from the hardware system, IT=8ms; (b) obtained from 







Figure 77. Spectra of the emission from RITC solutions and the mixture of RITC and PtOEP solutions, 
which was covered by a 0.50mm phantom (a) obtained from the hardware system, IT=500ms; (b) obtained 








Figure 78. Spectra of the emission from RITC solutions and the mixture of RITC and PtOEP solutions, 
which was covered by a 0.96mm phantom (a) obtained from the hardware system, IT=500ms; (b) obtained 









Figure 79. Spectra of the emission from RITC solutions and the mixture of RITC and PtOEP solutions, 
which was covered by a 1.24mm phantom (a) obtained from the hardware system, IT=500ms; (b) obtained 






5.4 Comparison of these two approaches of system optimization 
Table 10 is a comparison of the two optimization approaches. For the resolution of these two 
systems, it is determined by the band-width of the band pass filters of the two-detector system, 
whereas, it can be determined by the width of entrance slit of the customized spectrometer. Thus, 
changing the slits can enable the change of resolutions for the customized spectrometer, and 
changing filters also can enable the change of resolution for the two-detector system. Application 
of the two-detector system is limited to a degree by the filters and dichroic mirror, because the 
wavelength range is fixed. The application of the customized spectrometer is relatively more 
flexible that of the two-detector system, because as long as the emission is within the wavelength 
range of the grating in the customized spectrometer the emission can be measured by the 
customized spectrometer. For the application of luminescent sensor measurement, the two-
detector system can only measure two emissions, while the customized system can measure 
luminescent emissions of more than two dyes, if desired. If just intended for the measurement of 
two emissions, the CCD in the customized system can be replaced with discrete photodiode 
detectors to increase the photon capture efficiency, since the active area of the photodiode 
detector is often bigger than that of a 1-D CCD array. However, the two-detector system is easier 
to assemble and immobilize than the customized spectrometer.  The cost of these two systems 
are almost the same, each cost around $400. In experimental evaluations, both systems showed 
good SNR and the capability of working on a thick skin phantom (~1mm).  However, the spectra 
obtained by the prototype of the customized spectrometer showed more stray light and noise than 
the fiber bundle, which needs to be overcame in the future. The main source of stray light of the 
custom system is coming from the backscattered excitation light, since there is no ideal 
excitation filter and the fluorescent signal is always much weaker than that of excitation light. To 
reduce the stray light, another long-pass filter (575nm LP) will be needed to block more back 
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scattered excitation light leaking from the dichroic mirror, and some optics might need to be 
adjusted to reduce the aberrations. 
 
 
Table 10. Comparison of two optimization methods 
 Two-detector system Customized spectrometer 
Resolution adjustable adjustable 
Detectors photo-diode CCD array 
Extra Filters 3 0 
Simulation Compare photon counts on detector films 
Application Fixed pair of emission 
Luminescent emission within the 
wavelength range of the grating 
Complexity low more 





To deploy dermal implants for on-demand monitoring, a matched optoelectronic system for 
interrogation of sensors is needed. It was observed that the efficiency of the system designed in 
the last section was compromised due to losses from fiber connections and the entrance aperture 
of the commercial spectrometer used in experimental evaluation; >99.9% photons collected by 
the system were lost at the entrance plane of the current spectrometer. This finding highlights the 
different demands placed on optical sensors. The current trends of spectrometer design are aimed 
at obtaining high spectral resolution by minimizing the entrance aperture and slit width; this 
results in decreased signal due to the trade-off between spectral resolution and input energy. 
However, for luminescence measurements, it is common that only specific, relatively broad 
bands of the spectrum are of interest. Furthermore, luminescent signals collected from tissue or 
implants will be strongly attenuated by tissue scattering and absorption; therefore, signal power 
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should take priority over spectral resolution. Thus, a more appropriate high-efficiency hardware 
system to interrogate luminescent sensors is needed. Two optimization approaches were applied 
to solve the photon loss problem: a two-detector system and a customized spectrometer. 
Experiments of two-detector system in static in vitro experiment showed good SNR. The 
customized spectrometer was designed to maximize the throughput while maintaining a 
sufficient spectral resolution. Compared with the two-detector system, the customized 
spectrometer is more flexible, since the two-detector system is only able to measure one specific 
pair of luminescence emission, if the emission peaks change, (e.g. sensors are redesigned), the 
filters and mirrors have to be changed. However, the customized system has more stray light and 
noise, which need to be optimized in the future. Both systems overcome the problem of 
significant photon loss compared to commercial spectrometers by maximizing the input energy 
of luminescent photons while maintaining the required spectral resolution. The customized 
system can be directly coupled to an analog-to-digital converter and integrated circuits, which 
offers potential for a single compact and portable device for field use with luminescent 





 Dermally-implanted luminescent microparticle glucose sensors are being developed in 
our lab to enable minimally-invasive on-demand monitoring of glucose. To interrogate the 
sensors in vivo, it is necessary to design a matched optoelectronic system for delivery of 
excitation light, collection of luminescence, and measurement of luminescence the response with 
high efficiency. In my research, light propagation in skin and interaction with implanted 
microparticle sensors were studied using modeling, and an optical system based on the modeling 
results was designed, evaluated, and finally the optimization of the system was performed.  
 Three-dimensional, multi-wavelength simulations of light interaction with tissue and 
luminescent materials revealed the key factors influencing the generation and collection of 
fluorescence from sensors implanted in the dermis at different depths and concentrations, which 
provides critical information for the work of hardware design. The results of simulations to 
predict sensor in vivo performance showed that the spectral distortion resulting from the 
absorption and scattering of the skin, particle size, or particle concentrations has minimal 
influence over the predicted ratiometric measurements indicating that the in vivo data will only 
require minimal calibrations in the future.  
 An optical system of high efficiency to interrogate dermally-implanted microparticle 
sensors was designed and constructed. The silicone-based skin phantoms which match the 
maximum value of the published optical properties of human skin were developed as the 
permanent evaluation medium to minimize the animal use. This skin phantom is also useful in 
testing system design and facilitated system optimization of optical instrument system for dermal 
diagnostic. Experimental validations showed a good agreement with results of simulations, 
proving the accuracy of measured optical properties of developed skin phantom, and the 
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accuracy of the simulation system including Monte Carlo ray-tracing and geometric ray-tracing. 
Evaluation of the hardware system with developed skin phantoms indicated that there should be 
no obstacles for the optical hardware to meet expectations for in vivo analysis of implants. 
However, a significant photon loss was observed at the connections of hardware and the 
commercial spectrometer, which needs to be overcome for optimal performance.  
 Two optimization approaches were applied to solve the photon loss problem, and the 
two approaches are the two-detector system and the customized spectrometer. Experiments of 
two-detector system in static in vitro experiment showed good SNR. The customized system is 
hundred times more efficient to measure luminescent light than the fiber bundle and commercial 
spectrometer while the spectral resolution is still good enough. Compared with the two-detector 
system, the customized spectrometer is more flexible, since the two-detector system is only able 
to measure one specific pair of luminescence emission, if the emission peaks change, the filters 
and mirrors have to be changed. However, the customized spectrometer system has more stray 
light and noise, which needs to be optmized in the future. Both systems solve the problem of 
significant photon loss by maximizing the input energy of luminescent photons while 
maintaining the required spectral resolution.  
 In the future, a multi-layered skin phantom or micro-fluidic structured skin phantom can 
be developed based on the current work of skin phantoms to enable a more accurate skin 
phantom system. Though the system was designed for luminescent intensity measurement, 
because it separates fluorescence emissions spectrally, the detected signals can also be processed 
to measure the fluorescence life time. The optimized system can be modified into a more 
compact system, and it can be directly coupled to an analog-to-digital converter and integrated 
circuits, which offers potential for a single compact and portable device for field use with 
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